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Abstract 
Vincent, Jacob Adam. Ph.D., Biomedical Sciences Ph.D. Program, Wright State 
University, 2017. Sensorimotor Deficits Following Oxaliplatin Chemotherapy. 
 
 
 Neurotoxicity is one of the most significant side effects diminishing clinical 
efficacy and patient quality of life during and following chemotherapy.   Oxaliplatin (OX) 
is a platinum based chemotherapy agent used in the treatment of colorectal cancer.  
Colorectal cancer currently ranks as the 4th most common cancer, and the majority of 
patients receive OX as a part of their adjuvant therapy.  OX based adjuvant therapies 
significantly improve 5 year survival rates, however in many cases patients must stop 
treatment early because of the neurotoxic side effects.  OX causes two clinically distinct 
forms of neurotoxicity.  Acutely, within hours and for days following OX infusion patients 
experience positive symptoms including, paresthesia, cold induced pain, and muscle 
cramping/fasciculation.  These symptoms typically subside in between treatments but 
often worsen with each successive OX infusion.  Chronically, with accumulating doses of 
OX and following treatment cessation, patients experience negative symptoms including 
numbness, pain, and sensory ataxia.  The symptoms persist in a substantial number of 
patients for years following cessation of chemotherapy and significantly diminish quality 
of life.  While OX neurotoxicity has been widely studied, there are still fundamental gaps 
in knowledge regarding (a) the mechanisms underlying acute and chronic neurotoxicity, 
(b) the suggested causal link between acute and chronic OX, and (c) targeted treatment 
aimed at alleviating the neurotoxic side effects of acute and chronic OX.  In order to 
address these gaps we applied behavioral and in vivo electrophysiological techniques 
and pharmacological manipulation in chronic OX-treated, acutely OX-treated, and 
control rats.  Building on our recent discovery that following chronic OX-treatment 
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muscle proprioceptors cannot sustain repetitive firing necessary for normal encoding, we 
hypothesized that loss of proprioceptive signaling should result in behavioral deficits and 
that impaired encoding results from disruption of persistent inward Na+ currents (NaPIC).  
Using the methods above we confirmed these hypotheses and have developed a 
targeted treatment that restores proprioceptive encoding after chronic OX-treatment.  
Lastly, given the suggested link between acute and chronic neurotoxicity we sought to 
determine the location of changes in muscle proprioceptor excitability following acute 
OX-treatment.   
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Chapter 1: Purpose & Aims 
 
Purpose 
 Oxaliplatin induced neurotoxicity is a significant clinical problem that limits its 
clinical efficacy and negatively impacts patient lives.  Study of acute neurotoxicity has 
failed to provide any meaningful treatment of acute symptoms and has failed to prevent 
development of chronic neurotoxicity.  Similarly, chronic studies have focused solely on 
neuropathy and have failed to account for symptoms in patients without neuropathy.  
Studies undertaken in this dissertation seek to fill the gaps in the understanding of acute 
and chronic neurotoxicity.  Changes in muscle proprioceptor function will be analyzed 
following acute and chronic OX and changes in motor function will be analyzed following 
acute OX.  The purpose of these studies is to gain insight into changes that cause acute 
symptoms and chronic symptoms in the absence of neuropathy with the hope of 
identifying changes for targeted treatment. 
 
Specific Aims 
 In order to address the specific aims in this dissertation, electrophysiological 
techniques will be applied in vivo.  Studies are designed to characterize deficits in 
muscle proprioceptor encoding, how those changes correlate with behavior, and to 
identify the mechanism(s) responsible for those changes.  Further studies will be 
undertaken to test the ability of different agents to improve muscle proprioceptor function 
following chronic OX.  Lastly, muscle proprioceptor and motor function will be studied
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following acute OX in order to identify and localize clinically relevant changes in 
excitability that result in patient symptoms.  
 
Specific Aim 1: To test the hypothesis that OX treatment causes proprioceptive 
deficits by reducing ionic currents that support sustained repetitive firing 
necessary for sensory encoding 
 
Published: A novel path to chronic proprioceptive disability with oxaliplatin: Distortion of 
sensory encoding. Neurobiology of Disease. 2016 November; 95.  
  
 Complex impairment of Ia muscle spindle afferents following traumatic of 
neurotoxic injury.  Journal of Anatomy. 2015 August; 227  
 
Rationale 
 
 The recent observation that OX can produce sensory symptoms, including loss of 
cutaneous sensation, proprioceptive deficits, and pain in patients that have no evidence 
of neuropathy suggests that additional mechanisms are at play (Burakgazi et al., 2011). 
Support for this novel idea is found in that following chronic OX treatment muscle 
proprioceptors are unable to maintain repetitive firing necessary for sensory encoding.  
Specifically, Ia muscle spindle afferents fail to encode static muscle length, while effects 
on rapid stimuli are unaffected (Bullinger et al., 2011b).  Other muscle proprioceptors, 
group II and Ib golgi tendon organ afferents were also affected but to a lesser extent.  
Importantly, the animals used in these studies showed no evidence of neuropathy 
(Bullinger et al., 2011b).  Thus, disruption of sensory encoding by OX is a novel idea 
potentially explaining sensory symptoms in the absence of neuropathy.   
 The inability to sustain repetitive firing suggests that OX is disrupting an ionic 
current that supports repetitive firing during a sustained stimulus.  In dorsal root ganglion 
neurons and other neuronal subtypes, persistent inward currents (PIC) underlie 
repetitive firing during sustained stimuli (Lee and Heckman, 2001; Harvey et al., 2006a; 
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Xie et al., 2011).  In these various neuronal subtypes sodium persistent inward current 
(NaPIC) is essential for generating and maintaining repetitive firing.  If OX is disrupting a 
NaPIC necessary for normal sensory encoding, then drugs given acutely that block 
NaPIC should reproduce the OX firing phenotype.   
 
Specific Aim 2:  To test the hypothesis that drugs that increase persistent inward 
currents can restore sensory encoding following OX treatment.  
 
 
Rationale 
 
 Persistent inward currents have been identified in numerous neuronal subtypes 
including, motoneurons, dorsal root ganglion neurons, and cortical neurons (Crill, 1996; 
Lee and Heckman, 2001; Harvey et al., 2006a).  Their role is best defined in the alpha 
motoneuron where they have been shown to be essential for the generation and 
maintenance of repetitive firing (Lee and Heckman, 1998, 2001; Theiss et al., 2007).  
Preliminary evidence (Vincent et al., 2015) and results from aim 1 support the notion that 
chronic OX treatment disrupts a NaPIC resulting in encoding deficits in muscle 
proprioceptors.  The failure of muscle proprioceptors to maintain repetitive firing during 
static and slowly changing muscle length represent a critical loss of signal to the central 
nervous system.  These findings are the first suggestion outside of neuropathy to explain 
symptoms following OX.  Therefore, NaPIC is a potential therapeutic target following OX.  
If NaPIC can be increased after OX, then there is potential to restore the muscle length 
and force signals arising from muscle proprioceptors. 
 
Specific Aim 3: To determine if spontaneous activity following acute OX in muscle 
proprioceptors arises from sensory nerve terminals  
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Rationale 
 Within hours and for days following infusions of OX, greater than 90 % of patients 
describe abnormal sensations, pain, muscle spasm, and muscle fasciculation (Argyriou 
et al., 2008; Argyriou et al., 2014).  These symptoms typically last less than one week, 
but re-occur following every OX infusion (Krishnan et al., 2005; Park et al., 2009b; Park 
et al., 2011b; Park et al., 2013).  The common mechanism attributed to this acute 
syndrome is sensory and motor axonal hyper-excitability (Krishnan et al., 2006; Park et 
al., 2009b; Park et al., 2011b).  Support for this comes from several different studies 
showing OX alters the function of nodal voltage-gated Na+ channels either in vitro, or by 
clinically used techniques such as threshold tracking (Adelsberger et al., 2000; Grolleau 
et al., 2001; Benoit et al., 2006; Krishnan et al., 2006; Park et al., 2011b).   
 The importance of understanding OX acute effects is demonstrated by the 
correlation between the severity of acute symptoms and the likelihood of developing 
chronic neurotoxicity (Krishnan et al., 2005, 2006; Park et al., 2009a).  Information 
gained from previous studies has been used to identify neuroprotective strategies 
targeted at blocking the acute syndrome in order to prevent the chronic neurotoxicity.  
Unfortunately, these strategies have failed and there is no current effective treatment for 
blocking the acute syndrome and providing neuroprotection against chronic 
neurotoxicity.  Preliminary findings (Vincent et al., 2015) and results from aim 1 
demonstrate that changes following chronic OX occur at the sensory nerve terminal.  If 
acute and chronic neurotoxicity are linked then acute OX may also target the sensory 
nerve terminal.   
 In order to nail down the origin of hyperexcitability we will use in vivo intra-axonal 
recording, the gold standard for assessing axon parameters and novel spike triggered 
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averaging to localize spike origin.   These in vivo techniques will allow us to study the 
intact proprioceptor system in a way that has not previously been done. 
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Chapter II: Significance/Background 
 
Chemotherapy induced neurotoxicity is a poorly understood dose limiting side effect of 
chemo agents limiting the efficacy of cancer treatment:   
 
 Oxaliplatin (OX), a 3rd generation platinum chemotherapy drug, is one of the most 
commonly used adjuvant chemotherapeutic agents in the treatment of colorectal cancer.  
Colorectal cancer ranks as the 4th most common cancer, with nearly 140,000 new cases 
occurring each year (cancer.gov).  Currently there are nearly 1.2 million people living 
with colorectal cancer (cancer.gov), the majority of these patients receive OX as part of 
their adjuvant treatment.  The efficacy of OX treatment is limited by its neurotoxicity 
(Argyriou et al., 2014; Sereno et al., 2014), which forces many patients to stop treatment 
early (Argyriou et al., 2014).  OX neurotoxicity can be divided into two different phases.  
Up to 95% of patients experience acute neurological symptoms including paresthesia, 
muscle spasms, and cold hypersensitivity (Argyriou et al., 2008; Argyriou et al., 2013a).  
Acute hyper-excitability following treatment is related to changes in ions channels.  
Acute OX in vivo administration alters voltage-gated Na+ current in sensory and motor 
axons (Krishnan et al., 2006; Park et al., 2009b; Park et al., 2011b).  OX causes 
hyperpolarized shifts in the voltage dependent activation of voltage-gated Na+ channels 
(Adelsberger et al., 2000; Benoit et al., 2006).  These changes in voltage-gated Na+ 
current are thought to arise via Ca2+ chelation by oxalate, a metabolite of OX (Grolleau 
et al., 2001; Benoit et al., 2006; Argyriou et al., 2008; Argyriou et al., 2014).   
Additionally, OX has been shown to increase TRPA currents in sensory neurons 
contributing to the cold hypersensitivity (Zhao et al., 2012; Nativi et al., 2013).
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 Patients who continue OX treatment experience chronic neurological symptoms 
that are primarily sensory, including decreased cutaneous sensation, pain, 
proprioceptive deficits, and sensory ataxia (Bennett et al., 2012; Beijers et al., 2014).  
Clinically, these symptoms are commonly referred to as chemotherapy induced 
peripheral neuropathy (CIPN) and their severity is correlated with cumulative dose of 
OX.  In a self-report questionnaire patients reported feeling unsteady and clumsy, nearly 
falling over, difficulty walking and driving, and decreased sensation in their toes and 
fingers (Bennett et al., 2012).  Similar to other chemotherapy induced neuropathies, OX 
induced neuropathy is length dependent with the longest axons being effected first 
(Cavaletti, 2014).  The severity of neuropathy (peripheral axon loss) is scored using a 
combination of electrophysiology (reduced sensory nerve action potential amplitudes), 
epidermal punch biopsy (intra-epidermal nerve fiber density), and clinical assessment 
(sensory and reflex testing) (Burakgazi et al., 2011; Park et al., 2011a; Park et al., 
2012b). These dose limiting neurotoxic effects are evident in up to 90% of OX patients, 
with over 50% of those cases being either moderate (grade 2) or severe (grade 3) (Park 
et al., 2011a).  Neurological deficits can persistent for up to 2 years after treatment in up 
to 1/3 of patients (Park et al., 2011a).  The common accepted pathogenic mechanism of 
OX’s chronic effects results from its accumulation in the dorsal root ganglion where it 
causes decreases in cellular metabolism, oxidative stress, and axonal transport 
(Argyriou et al., 2008; Park et al., 2013; Argyriou et al., 2014; Briani et al., 2014; 
Cavaletti, 2014; Avan et al., 2015; Carozzi et al., 2015).  Within the dorsal root ganglion 
OX causes atrophy in large diameter neurons marked by parvalbumin (Jamieson et al., 
2005), and morphometric changes indicative of cell damage (Cavaletti et al., 2001).  
Changes in the dorsal root ganglion are associated with loss of axons in the periphery 
(Cavaletti et al., 2001).   
  
 
 
8 
OX Chronic Neurotoxicity: Additional Mechanisms 
 Within the clinical literature there is disparity between the clinical signs of 
neuropathy and patient reported symptoms.  Patients frequently report symptoms that 
are more severe than suggested by clinical measurements of neuropathy (Park et al., 
2013).  This disparity is supported by a recent clinical study that found subsets of 
patients that describe the same sensory symptoms in the absence of any clinical signs 
of peripheral neuropathy, i.e. reduced sensory nerve action potential amplitude (SNAP), 
or intraepidermal nerve fiber density (IENFD) (Burakgazi et al., 2011).  If patients 
experience sensory symptoms in the absence of neuropathy then there must be 
additional mechanisms contributing to sensory deficits.   
 Sensory symptoms experienced by patients could potentially be caused by either 
problems in the periphery, i.e. encoding or by changes that limit the transmission of 
sensory information to the central nervous system (CNS).  The focus of this dissertation 
is to investigate peripheral mechanisms other than neuropathy that could cause sensory 
deficits following OX treatment. 
 
Novel Peripheral Mechanism: OX Impairs Muscle Proprioceptor Encoding:  
 Recent evidence demonstrates that following OX treatment muscle proprioceptor 
sensory encoding is impaired (Bullinger et al., 2011b).  Muscle proprioceptors (muscle 
spindle and golgi tendon organs) lie within the muscle and supply the CNS with critical 
length and force feedback (Matthews, 1972).  More specifically, Ia muscle spindle 
afferents are activated by the stretch of their parent muscle.  These mechanical signals 
are encoded into action potentials out in the periphery and are conducted centrally 
where Ia muscle spindle afferents synapse with a wide variety of CNS neurons.  Most 
notably Ia muscle spindle afferents form a monosynaptic connection with alpha 
motoneurons (Matthews, 1972).  This connection forms the basis for the stretch reflex, 
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where stretching a muscle activates Ia muscle spindle afferents, which through their 
monosynaptic connection excite motoneurons, causing them to fire action potentials 
resulting in muscle contraction (Proske and Gandevia, 2009). This sensory feedback is 
essential for the sensorimotor control of locomotion (Proske and Gandevia, 2012).   
 In response to ramp-hold-release stretch (3 mm, 20 mm/s) normal rodent Ia 
muscle spindle afferents display a high frequency initial burst at the onset of stretch, 
followed by a rapid increase in firing until the peak of the ramp, and then a sustained 
discharge during the hold phase (Fig. 1 A).  Normal Ia muscle spindle afferents are 
slowly adapting (Fig. 1A), firing >800 ms through the 1000 ms hold phase of muscle 
stretch (Bullinger et al., 2011a; Vincent et al., 2015).  Following a 4-week OX (40 mg/kg 
cumulative dose) treatment regime and a 3-5 week coasting period, 50% of sampled Ia 
muscle spindle afferents fired ≤ 500 ms during the hold phase (Bullinger et al., 2011a; 
Vincent et al., 2015) (Fig. 1B).  The loss of hold phase firing was not due to an inability to 
conduct action potentials centrally, as shown in Fig. 1C Ia muscle spindle afferents were 
capable of conducting superimposed vibration with high fidelity.  The inability of Ia 
muscle spindle afferents to encode sustained muscle stretch results in the loss of critical 
length signal to the CNS.  This encoding deficit occurred in the absence of any 
neuropathy (Fig. 1 D, E) making it distinct from any previously described form of 
chemotherapy neurotoxicity.  
 
Muscle Proprioceptors: Muscle Spindles 
 Muscle spindles lie within the surrounding muscle, and are made up of intrafusal 
fibers surrounded by a capsule (Matthews, 1972; Hunt, 1974).  The intrafusal fibers 
within spindles orient themselves in parallel with the surround extrafusal tissue.  Their 
specific orientation with respect to the extrafusal muscle allows them to detect muscle 
stretch amplitude and velocity (Matthews, 1972; Hunt, 1974).   
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 The spindle structure can be divided in to two segments. Within the polar regions 
of the spindle central nuclei are sparsely spaced.  Near the center of the spindle is the 
equatorial region, which contains densely packed nuclei (Banks et al., 1982).  The 
intrafusal fibers within the equatorial region can be further divided into larger type 1 and 
type 2 nuclear bag fibers, and smaller nuclear chain fibers.  Intrafusal fibers receive both 
sensory and motor innervation (Boyd, 1968; Boyd and Ward, 1975; Boyd et al., 1977).   
 The first type of sensory innervation is the annulosprial endings of Ia muscle 
spindle afferents.  These endings form coils around the intrafusal fibers.  The second 
type of ending is referred to as a flower spray ending of group II muscle spindle 
afferents, and is most often found in the juxta-equatorial position (Barker, 1948; Hunt, 
1974; Banks et al., 1982; Banks et al., 2009).  Typically, each spindle receives 
innervation from a single Ia muscle spindle afferent and multiple group II muscle spindle 
afferents (Banks et al., 1982).   
 Proprioceptive afferents that innervate muscle spindles encode changes in 
muscle length, and velocity (Matthews, 1972).  As a group, given their in parallel 
orientation with the extrafusal fibers, muscle spindle afferents fail to firing during muscle 
shortening, such as during active muscle contraction (Matthews, 1972).  The 
responsiveness of these different muscle spindle afferent types to different stimuli allows 
for their distinction.  Ia muscle spindle afferents show a much higher dynamic stretch 
sensitivity, initial bursting at the onset of muscle stretch, and cessation of firing on 
release, and are uniquely sensitive to high frequency vibrations of 100-150 Hz 
(Matthews, 1972; De-Doncker et al., 2003; Haftel et al., 2004; Bullinger et al., 2011a).  
These properties allow Ia muscle spindle afferents to encode both muscle length and 
velocity changes.  In contrast, Group II muscle spindle afferents are much less sensitive 
to dynamic stretch, lack initial bursting, are relatively insensitive to muscle vibration, and 
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continue to fire upon release from stretch.  Group II muscle spindle afferents function as 
length sensors (Matthews, 1972; De-Doncker et al., 2003).    
 Muscle spindles are innervated by small motor axons arising from gamma 
motoneurons.  Gamma motoneurons are interspersed within their associated muscle 
motor pools within lamina IX of the ventral horn (Burke et al., 1977).  In comparison with 
alpha motoneurons, gamma motoneurons are much smaller, show less dendritic 
branching, and lack monosynaptic connection with 1a afferents and recurrent collaterals 
(Eccles et al., 1960; Burke et al., 1977; Lagerback, 1985).  Gamma motoneurons are 
modulated by supraspinal structures, however this input and therefore gamma 
motoneuron output is greatly decreased during anesthesia (Haftel et al., 2004).  
 Gamma motoneurons can be subdivided into dynamic and static groups.  The 
dynamic gamma axons innervate the type 1 nuclear bag fibers (dynamic Bag1 fiber), 
while the static gamma axons innervate the type 2 nuclear fibers (static bag2 fiber), and 
the nuclear chain fibers.  Each type 1 nuclear bag fiber is innervated by one or two 
dynamic gamma motor axons, while each type 2 nuclear bag and chain fibers are 
innervated by three to seven static gamma motor axons (Matthews, 1962; Matthews, 
1972; Boyd et al., 1977; Banks et al., 1982).  Gamma motoneurons extrinsically 
modulate muscle spindle output by contracting intrafusal muscle fibers (Boyd and Ward, 
1975).  Their segregated innervation results in differential modulation of dynamic and 
static responsiveness.   Dynamic gamma motoneurons cause an increase in the 
dynamic responsiveness, while static gamma motoneurons increase the static 
responsiveness of the muscle spindle afferent (Hunt, 1974; Boyd and Ward, 1975; 
Banks et al., 1997).  This is accomplished by contraction of intrafusal muscle fibers, and 
compressing the sensory nerve terminal.  At the onset of muscle lengthening, the 
shortened and taunt intrafusal muscle fibers stretch along with the sensory nerve 
terminal to a greater degree, allowing more current to flow into the sensory axon (Hunt, 
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1974; Boyd and Ward, 1975; Banks et al., 1997).  This results in an increase in firing 
during dynamic or static stretch depending on which intrafusal fibers were stimulated, i.e. 
Bag1, or Bad2/chain.   
 
Muscle Proprioceptors: Golgi Tendon Organ 
 In contrast to muscle spindles, golgi tendon organs consist of bundles of collagen 
oriented in series with the extrafusal muscle fibers (Hunt, 1974; Zelena and Soukup, 
1983; Jami, 1992).  Each golgi tendon organ receives innervation from a single group Ib 
golgi tendon organ afferent.  Given their in series orientation, Ib golgi tendon organ 
afferents increase their firing during active muscle contraction, distinguishing them from 
muscle spindle afferents (Houk et al., 1971; Matthews, 1972; Zelena and Soukup, 1983; 
Jami, 1992).  In fact, contraction of the motor unit in which a Ib golgi tendon organ 
afferent lies is considered their adequate stimulus.  Thus, Ib golgi tendon organ afferents 
are considered force sensors (Houk et al., 1971; Jami, 1992).  Their responsiveness to 
passive muscle stretch is thought to lie outside the physiological range of passive 
muscle stretch (Houk et al., 1971; Jami, 1992).  Other studies though have suggested 
that Ib golgi tendon organ afferents do in fact respond to passive muscle stretch within 
the physiological range (Stephens et al., 1975).     
 Together Ib golgi tendon organ afferents and muscle spindle afferents project 
into the spinal cord where they ascend through the dorsal spinocerebellar tract and 
dorsal column medial lemniscal system to supraspinal centers, and synapse with 
multiple targets within the spinal cord; including interneurons, and motoneurons.   
Together the circuits that these afferents feed into provide essential feedback about limb 
position, allowing for control of locomotion (Proske and Gandevia, 2012).     
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Mechano-transduction and Encoding  
 The arrival of action potentials within the central nervous system relies on three 
processes in peripheral signaling:  mechanotransduction, encoding of action potentials, 
and orthodromic conduction.  Mechano-transduction and encoding has been best 
described in Ia muscle spindle afferents.  Fig. 2 provides a diagrammatic representation 
of these processes.   Signaling begins with the stretch activation of mechanically gated 
ion channels allowing sodium (and to a lesser extent calcium) ions to enter the afferent 
terminal producing a depolarizing receptor potential (Hunt, 1974; Hunt et al., 1978; 
Bewick and Banks, 2015).  The size and shape of the receptor potential reflect the 
different dynamic and static components of mechanical perturbation. Recent evidence 
indicates that DEG/ENaC, and Peizo 2 channels may be responsible for the receptor 
potential (Hunt, 1974; Hunt et al., 1978; Bewick and Banks, 2015; Woo et al., 2015).  
After formation, the receptor potential spreads the unmyelinated heminode of the 
afferent where its features are encoded in firing patterns of action potentials by voltage-
gated Na+ and K+ channels. The final step in signaling proceeds as action potentials 
propagate from the heminodes orthodromically along the afferent axon as it traverses 
the peripheral nerve and enters the central nervous system.  
 The output of Ia muscle spindles can be modulated intrinsically by Ca2+ activated 
mechanisms (Bewick and Banks, 2015) and extrinsically by gamma motoneuron 
innervation of intrafusal muscle fibers (Taylor et al., 2006).  Muscle spindle afferent firing 
is reduced by negative feedback initiated within the heminode by action potentials that 
open P/Q-type Ca2+ channels.  This Ca2+ current suppresses afferent firing by activating 
large (BK) and small conductance (SK) K+ channels (Bewick and Banks, 2015).  This 
negative feedback mechanism suppresses afferent firing on a time scale of fractions of a 
second.  Additionally there is a distinct intrinsic mechanism that increases or maintains 
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spindle firing.  In this autogenic excitatory mechanism, increase Ca2+ causes glutamate 
release from synaptic like vesicles in the afferent terminal, which bind auto-genically to a 
PLD linked metabotropic glutamate.  This activates an unknown second messenger 
cascade that serves to increase afferent firing over a time course of minutes to hours 
(Bewick et al., 2005; Bewick and Banks, 2015). 
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Fig. 1. Chronic OX disrupts muscle proprioceptor encoding(Bullinger et al., 2011b; 
Vincent et al., 2015).  (A) Control slowly adapting Ia muscle spindle afferent firing 
response (gray lines are action potentials, black dots representation instantaneous firing 
rates) to ramp-hold-release stretch (bottom trace in B). (B) Following OX Ia muscle 
spindle afferents were unable to maintain hold phase repetitive firing, while encoding 
during the ramp phase was normal. (C) Superimposed 100 Hz vibration (bottom trace) 
restored firing during the hold phase. (D) Animals displayed no reduction in SNAP 
amplitude or changes in conduction delay. (E) Following OX treatment Ia muscle spindle 
afferents maintained normal innervation of muscle spindles. Staining the soleus muscle 
with PGP 9.5 demonstrates normal innervation and counts of muscle spindles as 
compared to controls.  Note the intact annulospiral ending of a Ia muscle spindle 
afferent.  
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Fig. 2.  Mechanosensory model of Ia muscle spindle afferent encoding adapted 
from Bewick and Banks 2015. Neural mechanisms in mechano-transduction and 
sensory encoding for Ia muscle spindle afferent fitted to muscle spindle structure 
including intrafusal muscle fiber (pink) wrapped by annulospiral ending (green) that 
extends unmyelinated followed by myelinated axon.  Mechano-transduction involves 
mechano-sensitive sodium channels (MSSC) and metabotropic glutamate receptors (M-
GLUR) that act through a phospholipase D (PLD) mechanism to modulate glutamate 
release from synaptic like vesicles (SLV); Sensory encoding mechanisms include BK 
and SK potassium channels activated by Ca2+; P/Q and T type Ca2+ channels; and 
voltage gated Na+ channels (NaV). 
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Chapter III: General Methods 
 
 Using in vivo electrophysiology in combination with behavioral analysis, this 
proposal will investigate the mechanism(s) underlying acute and chronic forms of OX 
neurotoxicity.  The general methods utilized are described in detail below. 
 
Animal Use 
 All animal procedures used are approved by Wright State University Laboratory 
Animal Care and Use Committee.  Detailed behavioral and electrophysiological analyses 
were performed on adult female wistar rats (250-300 g, Charles Rivers Laboratory 
Wilmington, VA). 
 
Anesthesia and Vitals 
 Rats were deeply anesthetized by isoflurane inhalation throughout the entire 
terminal experiment, beginning with induction in a closed chamber (5% in 100% O2) and 
continuing with delivery via a tracheal cannula (1.5–2.5% in 100% O2). Subcutaneous 
injections of lactated ringer solution were given to maintain adequate fluid levels and 
blood pressure. Respiratory rate, heart rate, oxygen saturation, and pCO2 were 
monitored to ensure anesthesia and overall animal health. Body temperature was 
recorded via a rectal probe, and maintained between 36 and 38 °C with heated water 
pads and a heat lamp.
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Surgical Technique 
 Surgical procedures based on Haftel et al. 2004 and Bullinger et al. 2011 (Haftel 
et al., 2004; Bullinger et al., 2011b) were used to dissect the hind limb and spinal cord in 
order to record afferent firing resulting from electrical stimulation and muscle stretch.  
Briefly, the rat was placed in a rigid recording frame, and the legs were placed into 
stereotaxis with the knee and ankle joints between 90-120°.  The left triceps surae 
muscles were isolated via their common Achilles tendon, and resting length was marked 
with suture.  The tendon was cut at the calcaneus, and the triceps surae was attached to 
a force and length-sensing servomotor (Model 305B-LR, Aurora Scientific Inc.) in order 
to apply muscle stretches and record length and force changes.   Triceps surae nerves 
were freed from the surrounding tissue and placed on a unipolar stimulating electrode 
(bipolar electrode in some instances), all other hind limb nerves including common 
peroneal, sural, and posterior tibial nerves were crushed.    A laminectomy was 
performed from T10-S1, and the dura mater was removed to expose the spinal cord and 
dorsal roots.  Skin flaps were tied up in the back and hind limb to create pools for 
mineral oil, in order to prevent the tissue desiccation.  During certain experiments ventral 
roots were sectioned to eliminate gamma motoneuron influence on muscle spindles.  
 
Recording Preparation/ Data Collection 
 Dorsal roots were isolated and placed on bipolar recording hook electrodes.  
Rootlets were tested for orthodromic action potential volley, and stretch sensitive activity.  
Within dorsal rootlets individual sensory axons were penetrated with sharp glass 
microelectrodes filled with 2M K+ acetate-.  Sensory axons were randomly sampled and 
selected for recording when they displayed orthodromic action potentials with a 
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conduction delay of < 3 ms following peripheral electrical stimulation of triceps surae 
nerves.  
 Sensory axons were characterized as either muscle spindle or golgi tendon 
organ based on response during the rising phase of twitch contractions of the triceps 
surae muscles; muscle spindles paused, while golgi tendon organ afferents accelerated 
during twitch contraction.  Further study of afferent firing was based responses to muscle 
stretch including ramp-hold-release (3mm, 20mm/s ramp, 1 sec hold), three successive 
triangular stretches (4mm/s, 3mm), vibration (50-250 Hz, 80µm), and ramp-hold-release 
(3mm, 20mm/s ramp, 1 sec hold) with superimposed 100 Hz vibration (80µm) during the 
1 sec hold phase.   Muscle spindle afferents were characterized as primary Ia when they 
displayed an initial high frequency burst at the beginning of the ramp or triangular 
stretch, 1:1 firing entrainment in response to ≥ 100Hz vibration.  Group II muscle spindle 
afferents paused firing during twitch contraction but failed to show initial bursting, or 1:1 
entrainment to ≥ 100Hz vibration.    All stretches were performed at resting length (Lr) of 
10g ± 3g, Lr+ 10g, and Lr+ 20g.  Intra-axonal records of action potentials and muscle 
length and forced changes were digitized (20 kHz), and stored on a computer for later 
analysis using Spike2 software. 
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Chapter IV 
 
Specific Aim 1: To test the hypothesis that OX treatment causes proprioceptive 
deficits by reducing ionic currents that support sustained repetitive firing 
necessary for sensory encoding 
 
Introduction 
 Previous study of muscle proprioceptors following OX demonstrated an inability 
to sustain repetitive firing during static muscle stretch (Bullinger et al., 2011b).  It was 
determined that the afferents were capable of firing during the time of static muscle by 
superimposing high frequency vibration, thus muscle proprioceptors were capable of 
firing but just failed to do so in response to static muscle stretch.  These results 
suggested that OX was impacting the encoding process (Bullinger et al., 2011b).  The 
loss of sustained firing by muscle proprioceptors is equivalent to a loss of static muscle 
length signal to the central nervous system.  We predict that this loss of signal will result 
in behavioral deficits.  One of the primary goals of this proposal is to corroborate the 
effect of OX on muscle proprioceptor encoding and to determine how it impacts with 
behavior. 
   The other primary goal of this study is to determine the mechanism(s) 
underlying OX disruption of muscle proprioceptor encoding.  The effects of OX on hold 
phase repetitive firing suggest that OX may be disrupting ionic currents that support 
repetitive firing.  An inability to repetitively fire suggested a problem with persistent 
inward Na+ current (NaPIC) (Lee and Heckman, 2001; Bullinger et al., 2011b; Xie et al., 
2011).  NaPIC is essential for repetitive firing in many different groups of neurons:
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motoneurons, cortical neurons, prebotzinger neurons, and large diameter dorsal root 
ganglion neurons (Lee and Heckman, 2001; Ptak et al., 2005; Harvey et al., 2006a; Xie 
et al., 2011).  These currents activate subthreshold causing a subthreshold plateau in 
membrane potential that helps limit Na+ channel inactivation during the slow 
depolarization at the end of the afterhyperpolarization (Harvey et al., 2006a).  If OX is 
disrupting NaPIC necessary for sustained repetitive firing then additional signs of 
impaired repetitive firing are expected from muscle proprioceptors.  We know for 
instance, in motoneurons NaPIC role in supporting repetitive firing is dependent on the 
speed of depolarization (Harvey et al., 2006a).  During slow depolarization, without 
NaPIC inactivation of the transient Na+ channel prevails, preventing action potential 
formation (Harvey et al., 2006a).  Therefore, OX should disrupt repetitive firing during 
slow muscle stretch, supporting its role in disrupting NaPIC.   
 If OX is disrupting a NaPIC necessary for repetitive firing, then pharmacological 
agents that block NaPIC injected acutely should reproduce the firing deficits observed 
following OX.  Riluzole and phenytoin are two drugs that have been shown to block 
NaPIC (Zeng et al., 2005; Theiss et al., 2007; Bellingham, 2011; Xie et al., 2011).  If OX 
is disrupting NaPIC, then riluzole and phenytoin should similarly reduce repetitive firing 
in muscle proprioceptors and will provide the first insight into the underlying mechanism 
of deficits following OX. 
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Methods 
 
Chronic OX Studies 
 These studies were designed to test effects of chronic OX treatment. Oxaliplatin 
(BIOTANG, Lexington, MA) dissolved in 5% dextrose was ad-ministered via 
intraperitoneal (i.p.) injection once per week (except week 4 when OX was unexpectedly 
unavailable) in single doses of 10 mg/kg to reach a cumulative dose of 70 mg/kg over 8 
weeks. Ten female rats received these injections concurrently with five female rats that 
served as sham controls receiving only vehicle (5% dextrose i.p.) on the same schedule. 
OX effects were assessed by studying rats over a period of 14 weeks spanning periods 
before, during and after injections. Throughout this period, each rat was closely and 
frequently monitored for pain or distress. No individual rat reached set criteria 
established for early removal from the study, e.g. 20% weight loss, vocalization, failure 
to drink or groom, severe lethargy, self-mutilation, uncontrollable infection.  
 Repeated measures of body weight, motor task performance, and tail nerve 
conduction were obtained from all rats before electrophysiological recordings were made 
in terminal experiments, all as described below. 
 
Behavioral Testing and Other Repeated Measures  
 Over the course of the study all 15 animals were handled by two individuals who 
were responsible for all behavioral testing, weight measurements, SNAP recordings, and 
OX treatment. The ladder rung walking task was chosen for its validated use to detect 
and describe sensorimotor deficits (Metz and Whishaw, 2002, 2009; Akay et al., 2014).  
All 15 rats were introduced and trained on the horizontal ladder run apparatus in a single 
session lasting 4 hours one week prior to the start of the study. Rats were trained to 
traverse the apparatus in the same direction in order to reach their home cage. 
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Behavioral testing was performed once per week at the same time of day on different 
days each week, and lasted approximately 4 h. During a test session, each rat traversed 
the apparatus 5 times. On separate days animal weight and SNAPs were recorded (see 
below). Behavioral sessions were video recorded using a high definition camera 
(Samsung F90 HD Camcorder) aimed toward the left side of the animal; a mirror was 
placed on the right side of the apparatus to allow clear visibility of the right hind limb (Fig. 
1B). All videos were imported onto a laptop computer and exported as QuickTime videos 
that were stored for analysis. The person performing all analysis was blinded to which 
rats received treatment. All results were compiled and were subsequently decoded for 
statistical analyses.  
 
Ladder rung: Horizontal Apparatus  
 The ladder rung apparatus was built as previously described (Metz and 
Whishaw, 2002), consisting of two Plexiglas walls, 1 m × 0.3 m, connected at the bottom 
with 1/8 in (~3 mm) diameter steel rods (rungs). Rungs were set at irregular intervals, 
with a maximum of 5 cm and a minimum of 1 cm distance between rungs. Holes drilled 
for rungs were 1 cm apart, across the entirety of the Plexiglas, allowing for different 
iterations (6 iterations were used in total) of rung patterns, preventing animals from 
learning any single pattern.  
 
Analysis of Hind Foot Placement  
 Two measures of hind foot placement: secure placement, and correct placement 
were analyzed in control and OX treated animals. All steps taken during ladder walking, 
from first to last were included in the analysis (Antonow-Schlorke et al., 2013). Once 
analyzed, the data were averaged and are presented as percent of change, week 0 
scores were analyzed, averaged and are represented as zero.  
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Analysis of Secure Placement  
 Secure hind foot placement was assessed using the seven-category scale 
scoring system introduced by Metz and Whishaw (Metz and Whishaw, 2002, 2009). The 
scoring system, which distinguishes misses, slips, and placement errors in rung contact, 
was slightly modified by assigning a score of 0 whenever the foot entirely missed a rung, 
whether or not it was associated with a deep fall. Based on the scoring system above, 
error was defined as a score of 0–2. The total number of errors in hind foot placement 
was calculated with no distinction between right and left, and the mean error/step ratio 
was calculated for all five trails and represented as percent of error. This number was 
multiplied by −1 in order to convert the values into a measure of the number of secure 
placements rather than the number of errors per steps. Thus an increase in the number 
of errors/steps corresponds to a decrease in secure hind foot placement of the hind foot.  
 
Analysis of Correct Placement  
 During ladder rung walking, normal rats tended to place their trailing hind foot on 
the exact same rung as the ipsilateral front foot, defined here as correct placement of the 
hind foot; sequential placement of the ipsilateral hind foot on a different rung was defined 
as an error in placement and supposed to reflect impaired proprioceptive ability. Placing 
the hind foot on an incorrect rung, and then replacing to the correct rung, was still 
considered an error in placement. Correct hind foot placement was defined as the 
number of errors/steps multiplied by −1. The total number of errors was counted and 
expressed as an average of error/step ratio for both hind limbs. Multiplying this number 
by −1 gives a value for correct placement. Thus as the number of errors/ steps 
increases, the value for correct hind foot placement decreases. 
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Sensory Nerve Action Potentials (SNAPs)  
 At the end of each behavioral test session, rats were temporarily anesthetized 
with isoflurane inhalation via nose cone (2–4% in 100% O2) in order to record SNAPs as 
described in our earlier reports (Novak et al., 2009; Bullinger et al., 2011b).  Two pairs of 
needle electrodes were inserted sub-dermally in the tail: one pair near the base of the 
tail for recording SNAPs (compound action potentials) evoked by electrical stimulation 
through the other pair located 2 cm distally. A ground electrode was inserted near the 
recording electrodes. An electrical stimulus of 10 mA was applied to elicit and record the 
SNAP using a Nicolette Viking Quest nerve conduction machine (Natus, Pleasanton, 
CA). Before removal of electrodes, a permanent marker was used to re- cord the 
position of the electrodes, enabling exact placement of the electrodes for the duration of 
the study.  
 
 Terminal Experiments  
 Electromechanical responses of individual proprioceptors were examined 
electrophysiologically in terminal experiments performed on all rats, including those used 
to study the behavioral effects of OX treatment and those dedicated solely for studying 
the acute effects of riluzole and phenytoin on sensory signaling. 
  
Acute Pharmacological Studies 
 Twenty-two rats having received no prior treatment or study were used to 
measure proprioceptor firing responses in terminal electrophysiological study exactly as 
described above. Individual muscle proprioceptors were randomly sampled both before 
and after i.p. injection of riluzole (16 rats), phenytoin (4 rats), or vehicle alone (DMSO in 
saline). Riluzole was given in doses of 4 mg/kg (4 rats), 6 mg/kg (8 rats), and 10 mg/kg 
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(4 rats), and phenytoin was given in a single dose of 20 mg/kg dose. Vehicle consisted 
of 1 mL DMSO combined with 4 mL 0.9% saline. 
 
Data Collection from Muscle Proprioceptors 
 Intra-axonal records from individual muscle proprioceptors were obtained as 
described in the general methods section.  The parameters recorded from individual 
muscle proprioceptors are described next.  Dynamic and static responsiveness of 
proprioceptors were measured as different parameters of firing occurring, respectively 
during changing and constant muscle length.  Dynamic response parameters included 
rate of initial burst firing at the onset of fast ramp stretches, the rate of firing rates at the 
peak of ramp stretch (peak firing rate). Dynamic thresholds were recorded as the length 
change necessary to generate sustained repetitive firing during fast and slow ramps. 
Measures of static responsiveness were measured during the hold phase of ramp-hold-
release stretches as the duration and average rate of repetitive firing.  
 
Results 
 
Proprioceptive Movement Deficits in OX-treated Rats  
 In previous study of chronic OX-treatment in rats, we demonstrated defects in 
sensory signaling by muscle proprioceptors (Bullinger et al., 2011b). Because these 
signals are critical for detecting and guiding limb position and movement, we predicted 
deficits in movements that rely on sensory feedback about limb position (see 
Introduction). In order to assess sensorimotor function in rats, we tested their 
performance in walking over horizontally arranged ladder rungs (Metz and Whishaw, 
2002, 2009). As rats move with vision directed forward, success in walking relies on 
proprioceptive function that assists with foot placement on rungs that pass out of sight 
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(Fig. 3B).  
 Performance measures in ladder rung walking are illustrated in Fig. 3. All values 
are expressed as percent change per rat from scores obtained in early task sessions 
(time 0). Plots for secure (Fig. 3A) and correct hind foot placement (Fig. 3C) illustrate 
sensorimotor function for each OX-treated rat over time in relation to the mean and 95% 
confidence intervals computed from values pooled from all five sham control rats. A 
general pattern emerged over time with values for secure and correct hind foot 
placement falling below control confidence intervals, despite some tendency for both OX 
and control rats to improve performance with time. Divergence from control values 
appeared as early as one week after the first OX dose and continued through the last 
measurements made 3 weeks after OX-treatment was discontinued.  
 Closer inspection of Fig. 3 shows the following: First, OX-rats exhibited 
considerable variability both among individuals and within individuals across time. 
Compare, for example, secure hind foot placement (Fig. 3A) that was poor throughout 
and after treatment for OX-rat #3, not distinguishable from normal for OX-rat #5 until 
treatment was complete, and never abnormal for OX-rat #2. In this respect, our rat 
model reproduces the high degree of variability also observed for the OX patient 
population, in which subjective assessment of motor ability varies between and within 
individuals (Bennett et al., 2012). Second, Fig. 3A shows that values for secure hind foot 
placement in OX-rats rarely exceeded control means and were never higher than the 
control 95% confidence intervals. This contrasts with values for correct hind foot 
placement (Fig. 3C), which for some OX rats (#4 and #8) were better than normal. Thus, 
rats capable of correct placement were unable to make secure contact, e.g. slips 
occurred as shown in Fig. 3B. Although these differences between performance in 
secure vs. correct hind foot placement may prove to be important if verified in a larger 
study, there was nonetheless qualitative agreement between these measures in 7/10 OX 
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rats at the time of the last performance measurement (Fig. 3D).  
 OX-rats were routinely observed for a number of additional factors that might 
have contributed to poor sensorimotor performance. Although OX-rats did not increase 
body weight as seen in the sham control rats over the study period, both sham control 
and OX-rats gained weight. Mean body weight increased 20% for sham controls 
compared to 10.5% for OX-rats. Following each treatment, OX rats were also less active 
and had lower appetites. Otherwise, OX-rats exhibited no deterioration in general 
condition, e.g. severe lethargy, piloerection or failure to groom. During behavioral test 
sessions, OX animals exhibited similar climbing and gripping capabilities as control rats. 
From the latter observations, we rule out weakness as the basis for poorer than normal 
motor performance.  
 Severe neuropathy, involving dying-back degeneration extending into the 
peripheral nerve was assessed by measuring SNAPs from the rats' most distal 
extremity, the tail, at the end of each behavioral test session. We found no significant 
difference (p > 0.05) between OX and control rats over time consistent with our earlier 
study (Bullinger et al., 2011b). Even by the end of behavioral testing, OX-rats were not 
different than control, respectively, in either SNAP amplitude (mean ± SD; 0.30 ± 0.04 
mV, 0.33 ± 0.08 mV) or latency (mean ± SD; 0.80 ± 0.08 ms, 0.82 ± 0.08 ms). These 
findings rule out the occurrence of neuropathy severe enough to cause axon 
degeneration in parent sensory nerves, as it does in some though not all OX patients 
(Burakgazi et al., 2011). However, this measure does not assess degeneration of the 
distal most endings of sensory neurons (see Discussion).  
 
Proprioceptor Impairment Occurred Together with Proprioceptive Movement Deficits  
 As a test of our hypothesis that proprioceptive encoding deficits contribute to 
poor motor performance, we performed in vivo electrophysiological studies on all OX 
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treated rats at the conclusion of behavioral evaluation in weeks 12 and 13 (cf Fig. 3A,C 
time scale). Analyses focused on Ia muscle spindle afferents, for which per-animal 
sample sizes were largest. Fig. 4 compares firing behavior of Ia muscle spindle afferents 
sampled from sham control and OX-rats. A conspicuous group difference was found in 
static responsiveness, i.e. the firing that occurs during the static (hold) phase of muscle 
stretch. Records taken from a control rat (Fig. 4A) show that repetitive firing was 
sustained throughout static stretch, which is typical for normal Ia muscle spindle 
afferents and which classifies them as slowly adapting sensory neurons (Lewin and 
McMahon, 1991). In sharp contrast, records from an OX-rat (Fig. 4B) show that firing 
was absent during most of static stretch. The reduction in static responsiveness for OX 
rats as a group averaged >50% (Fig. 4D, Table 1). These findings corroborate the 
abnormally low static responsiveness that we reported earlier for OX treated rats 
(Bullinger et al., 2011b).  
 The average magnitudes of impairment in proprioceptor signaling and behavioral 
performance were compared among individual OX rats. Fig. 4E shows a significant 
positive correlation between how securely the hind foot was placed on the rungs and the 
duration of Ia muscle spindle afferent static responsiveness (r2 = 0.76, p < 0.01). Static 
responsiveness was not significantly related to correct hind foot placement.  
 
Mechanisms of Impaired Proprioceptor Signaling in OX-treated Rats  
 At the time during static muscle stretch when Ia muscle spindle afferents failed to 
fire, superimposition of mechanical vibration, a fast-dynamic muscle stretch was 
perfectly effective in eliciting firing (Fig. 4C). Thus, the loss of static responsiveness was 
not attributable to inability either to generate or conduct spikes centrally, since the Ia 
muscle spindle afferent remained responsive to fast dynamic mechanical stimulation 
produced by muscle vibration. Instead we speculated that reduced static responsiveness 
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originated from impairment of underlying persistent inward current mechanisms. If this 
were the case, then additional signs of firing impairment would be expected, as they are 
with suppression of persistent inward currents in other neuronal systems (Harvey et al., 
2006a). Specifically, we expected that the threshold for repetitive firing in OX rats would 
remain unchanged during fast ramp stretch (20 mm/s), but would increase during for 
slow ramp stretch (4 mm/s). Results illustrated in Fig. 5 confirmed our expectation. 
Threshold for repetitive firing increased by about 60% with slow but not fast dynamic 
stretch in OX-rats (Fig. 5C,F, Table 1). Comparison of Fig 5A and B provides insight into 
the change in threshold. In control rats, repetitive firing is immediately preceded by an 
initial burst of rapid firing, which occurs at the onset of fast dynamic stretch and in the 
first of three sequential slow dynamic triangular muscle stretches (Fig. 5A; Haftel et al., 
2004). That initial burst was not lost in OX-rats (Fig. 5B), and it occurred at the same 
threshold for control and OX-rats (see Table 1). These findings indicate that in OX rats, 
increased threshold was specific to repetitive firing and was not an expression of general 
insensitivity to mechanical stimulation.  
 
Pharmacological Block of NaPIC Mimics Proprioceptor Impairment with OX  
 Repetitive firing in response to a static stimulus relies in many neurons on 
persistent inward current mediated by Na channels (Crill, 1996; Lee and Heckman, 
1998, 2001; Harvey et al., 2006a). If OX treatment altered proprioceptor signaling 
through this mechanism, then we expected to mimic its effect by reducing sodium 
persistent inward current (NaPIC) in normal rats. Riluzole was selected for its known 
effects in blocking NaPIC and repetitive firing in the large diameter class of DRG 
neurons that include muscle proprioceptors (Xie et al., 2011).  
 Fig. 6 illustrates the effect of acute riluzole injection on the static responsiveness 
of Ia muscle spindle afferents in normal rats For Ia muscle spindle afferents sampled 
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from a single rat, comparison of Fig. 6A with 6B demonstrates a reduction in static 
responsiveness similar to that shown for OX treatment (Fig. 4). Fig. 6D demonstrates 
that the reduction in static responsiveness was dose dependent. By comparison, OX 
reduced static responsiveness by about 60% (Fig. 4; Table 1), an amount found for 
riluzole concentrations between 6 and 10 mg/Kg. If we speculate that OX acts through 
the same mechanism as riluzole, possibly block of NaPIC, then we would suggest that 
NaPIC is only partially impaired by OX treatment.  
 Additional effects of acute riluzole were studied as they were for OX treatment. 
Fig. 6C shows that Ia muscle spindle afferents remained sensitive to fast dynamic 
mechanical stimulation produced by muscle vibration, just as in OX-rats (cf. Fig. 4C). 
Fig. 7 shows that riluzole increased the threshold for repetitive firing in response to slow 
stretches, and affected fast stretches only at the highest dose (cf. Fig. 5 for OX rats). 
Table 1 compares riluzole (at the intermediate dose of 6 mg/kg) and OX treatment for 
their effects on additional Ia firing parameters. The match is nearly identical between 
those parameters that either were or were not significantly different relative to control. 
The one exception was peak firing rate which was nominally reduced by riluzole, but not 
significantly so as it was with OX treatment. Collectively, these findings are consistent 
with the possibility that OX treatment impairs proprioceptor signaling by reducing NaPIC.  
Table 1 revealed differences between the control groups for riluzole vs. OX that bear 
consideration. Riluzole control values were taken from Ia muscle spindle afferents 
sampled from single rats before riluzole injection, and those values are similar to control 
values recorded from untreated rats in an earlier study (Bullinger et al., 2011b). 
However, the OX controls were different from riluzole controls for nearly every 
parameter. We can only speculate that the OX controls were influenced by the 
behavioral study protocol or by vehicle injection, nonetheless, these data provide the 
appropriate controls for OX treated rats, which underwent the same protocol.  
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 Riluzole might have reduced Ia static responsiveness through its known action of 
blocking NaPIC in motoneurons (Harvey et al., 2006a; Theiss et al., 2007). Through this 
action, riluzole might decrease activity of gamma motoneurons, which play a critical role 
in setting Ia sensitivity to muscle stretch (Crowe and Matthews, 1964; Matthews, 1972). 
To determine whether a loss of gamma modulation of muscle spindle gain might underlie 
OX-induced encoding defects, we sectioned ventral roots (where gamma motoneuron 
axons exit the spinal cord) and recorded spindle encoding in both controls and riluzole 
injected rats. Ventral root section had no significant effect (p > 0.05) on Ia muscle 
spindle afferent static responsiveness. In control rats, there was no significant difference 
in the duration of static responsiveness with ventral roots intact (746 ± 315 ms) or ventral 
roots cut (790 ± 269 ms). Neither did the effect of riluzole depend on gamma 
motoneuron input, since riluzole reduced the duration of static responsiveness to levels 
that were not significantly different (p > 0.05) with ventral roots intact (423 ± 438 ms) or 
cut (518 ± 404 ms).  
 Mechanistic interpretation of the riluzole effect is confounded by its multiple drug 
actions. In addition to blocking NaPIC, riluzole activates calcium dependent potassium 
channels (BK/SK) (Grunnet et al., 2001; Wang et al., 2008), inhibits voltage-gated Ca2+ 
channels (Huang et al., 1997; Stefani et al., 1997), and modulates glutamate signaling 
and release (Doble, 1996; Lamanauskas and Nistri, 2008; Bellingham, 2011, 2013), all 
of which are present in muscle spindles (Bewick and Banks, 2015). In attempt to narrow 
the set of possible explanations for the riluzole effect, we tested acute injection of 
phenytoin, which also blocks NaPIC (Lampl et al., 1998; Zeng et al., 2005), but does not 
share the other actions with riluzole. The effects of phenytoin on Ia muscle spindle 
afferent firing were similar to those of riluzole and OX treatment. Fig. 8 shows the 
shortening of firing duration during static muscle stretch described above for OX 
treatment and matched to the effect of riluzole at its intermediate dose (6 mg/Kg). The 
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reproduction of impaired Ia firing in OX-rats by two drugs having predominantly only 
NaPIC blockade in common leads us to the parsimonious though provisional conclusion 
that OX reduces static and slow dynamic responsiveness of Ia muscle spindle afferents 
by reducing NaPIC in the proprioceptor's peripheral nerve terminals.  
 
Encoding Deficits are Present in Other Muscle Proprioceptors  
 The large diameter group II muscle spindle afferents and group Ib tendon organ 
afferents are also muscle proprioceptors that provide essential feedback regarding 
muscle length and force (Matthews, 1972; Jami, 1992). Fig. 9 illustrates the effects of 
OX treatment and riluzole on static responsiveness of these two proprioceptors. For 
group II proprioceptors, static responsiveness shifted, but only slightly and insignificantly 
toward lower than control values in OX rats, although riluzole in the highest dose studied 
here produced a substantial and significant decrease. For Ib golgi tendon organ 
afferents, there was a significant reduction in responsiveness with OX treatment and 
with acute injection of riluzole. This finding had unique value in establishing that impaired 
sensory firing did not require the functional and structural specializations that are present 
in muscle spindles but absent in tendon organs (Hunt, 1974). We suggest, therefore, 
that these findings localize impairment of static responsiveness to the nerve terminals of 
proprioceptors. 
 
Discussion 
 
 Recently our laboratory discovered that chronic treatment with oxaliplatin in 
rodents produces a selective deficit in sensory encoding by muscle proprioceptors 
(Bullinger et al., 2011b). In particular, sensory neurons supplying muscle spindle 
receptors lose their ability to signal stationary muscle position. Given the primacy of 
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proprioceptor signals for informing the central nervous system about limb position 
(Prochazka and Ellaway, 2012; Proske and Gandevia, 2012), we predicted, and in the 
present study we demonstrated that movements relying on proprioceptive feedback 
were impaired in OX-treated rats. This finding motivated us to further explore the cellular 
mechanisms underlying impaired sensory signaling. Our findings suggested that OX 
treatment chronically impairs proprioceptors through ion-channel mechanisms, which 
present possible therapeutic targets for relieving some of the disabling effects of OX 
chemotherapy.  
Movement Disability with Proprioceptor Impairment  
 Sensory information provided by muscle proprioceptors is indispensable to the 
production of normal movements and postures of body and limbs (Prochazka and 
Ellaway, 2012; Proske and Gandevia, 2012). These receptors are distributed in nearly all 
mammalian skeletal muscles where they encode dynamic and static parameters of 
muscle length and force. Muscle proprioceptors are the major source of sensory 
feedback used to control movements that are unassisted by visual input or vestibular 
sense, e.g. reaching for an object outside the visual field. Sensory feedback from muscle 
proprioceptors is critical not only for making rapid adjustments to unexpected movement 
conditions (Nichols et al., 1999; Shemmell et al., 2010), but also for maintaining body 
schema, i.e. a sensorimotor representation of the spatial relations between body parts 
that is used in guiding voluntary movement (Ivanenko et al., 2011). It follows then that 
any conditions which interrupt sensory detection, encoding or signal transmission to the 
central nervous system have the potential to result in postural instability, clumsiness, 
and ataxia as has been found under a variety of conditions in rodents, cats, and humans 
(Krinke et al., 1985; Abelew et al., 2000; Sghirlanzoni et al., 2005).  
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 In rats receiving chronic OX treatment, we observed abnormal motor behavior 
characterized as difficulty with achieving proper limb placement. The following 
observations suggest a link to altered proprioceptor signaling. First, the behavioral task 
that OX-treated rats struggled with was one that accentuated reliance on proprioceptor 
signaling. Specifically, rats walked on ladder rungs, a task that required them to position 
hind feet on unevenly spaced rungs that passed outside their visual field as they stepped 
forward; rung positions were randomly changed between sessions to prevent advanced 
knowledge of their position (Metz and Whishaw, 2002, 2009). This task exposed 
substantial errors in placing the foot securely and correctly beginning within the first two 
weeks of OX treatment and extending until the last measurements taken at three weeks 
after OX treatment. Disability was not attributable to muscle weakness, for which we 
found no evidence in the rats' general behavior, e.g. climbing onto objects, or recovering 
from missteps or falls on the ladder rung apparatus. Second, the same OX rats that 
performed poorly in the proprioceptive movement task also exhibited impaired sensory 
signaling in terminal electrophysiological study of muscle proprioceptors. In fact, we 
found a significant correlation in the magnitude of abnormalities measured in animal and 
proprioceptor behavior. Third, difficulties with limb placement tested in the ladder rung 
test are also found in mice in which muscle spindles are selectively eliminated by 
experimental genetic mutation (Akay et al., 2014). These observations support a 
possible causal relationship between movement disorders and modified proprioceptor 
firing observed here for OX treated rats.  
 
Assessing Patient Relevance  
 With OX chemotherapy, patients report difficulties often characterized as 
proprioceptive disability, including instability when walking and clumsiness with 
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manipulating objects ((Bennett et al., 2012). There are good reasons to propose that 
these movement deficits originate from impaired signaling by muscle proprioceptors. As 
muscle proprioceptors are the sole source for detecting and signaling of muscle position 
and force in rats and all other mammalian species studied thus far (Matthews, 1972; 
Zelena and Soukup, 1983; Jami, 1992), so too are they the origin of this information in 
humans. Muscle spindles and tendon organs in humans resemble those in rats and 
other animals in their structure and neural innervation (Swash and Fox, 1972; Nitatori, 
1988; Eriksson et al., 1994; Liu et al., 2003) and in their encoding of dynamic and static 
parameters of muscle conditions, including their sustained (slowly adapting) firing during 
fixed muscle length or force (Edin and Vallbo, 1990a, b, c; Macefield, 2005). 
Experimental manipulations of proprioceptor signaling in humans, e.g. temporarily 
silencing muscle proprioceptors by nerve compression (Walsh et al., 2010; Inui et al., 
2011) demonstrate their necessity for normal movement. Additionally, destruction of 
muscle proprioceptors in human victims of large fiber neuropathy leads to clumsiness, 
ataxia and inability to properly position limbs outside visual field (Rothwell et al., 1982). 
These observations establish strong parallels between humans and another animal 
species with respect to proprioceptor signaling and its requirement in producing normal 
movement, and they support our assertion that the effects of OX on proprioceptive 
signaling and behavior that we observe in rats are likely to have relevance for patients.  
 
Role of Neuropathy  
 Signaling by primary sensory afferents might be obstructed through any one of 
several processes and locations, ranging from sensory detection or encoding at afferent 
endings to conduction and transmission by afferent axons and central synapses. The 
best documented cause of chronic sensory impediment by OX chemotherapy is 
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neuropathy, occurring as a length-dependent dying back from the distal ends of the 
longest sensory axons supplying distal limbs, e.g. feet and hands (Avan et al., 2015). 
The possibility that neuropathy contributed to present results cannot be definitively 
discounted. Although we found no evidence of neuropathy in SNAPs measured from the 
long sensory axons in the rat tail, we did not directly test for histological signs of 
degeneration in sensory nerve terminals. While acknowledging uncertainty, the following 
several observations suggested to us that neuropathy was probably not a major 
contributor to our results. First, none of the proprioceptors sampled from OX rats 
generated action potentials in response to electrical stimulation of nerve (1 cm proximal 
to muscle entry) without also firing in response to muscle stretch, thereby giving no 
evidence that sensory terminals had degenerated in advance of parent axons. Second, 
direct histological examination in our earlier study showed that the sensory innervation of 
muscle spindles was not retracted and was grossly normal in appearance (Bullinger et 
al., 2011b). It is important to note, however, that the cumulative dose of OX was raised 
from 40 mg in that previous study to 70 mg in the present study, in order to better match 
the dosage in humans. A cumulative dose of 70 mg/kg in rats is equivalent to 
approximately 415 mg/m2 in humans (Freireich et al., 1966; Reagan-Shaw et al., 2008), 
a dose that is at just threshold for the earliest detection of neuropathy measured from 
changes in SNAP amplitude (Grothey, 2003) and well below levels, >700 mg/m2, that 
produce robust neuropathy (Argyriou et al., 2008; Avan et al., 2015). Thus we may not 
expect the higher dose used in the present study to produce substantially more 
neuropathy in our OX treated rats, and this supposition is supported by the similarity in 
OX effects on the mechano-responsiveness of proprioceptors sampled in this and our 
previous study (cf Table 1 from each paper). Third, the chronic effects of OX were 
stereotypical in affecting static firing exclusively and did not express widely varying 
changes in firing behavior that one would expect from individual proprioceptors in 
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different stages of sensory terminal degeneration. None of these observations are easily 
reconciled as evidence for neuropathy.  
 While evidence for neuropathy in patients is in many cases incontrovertible and 
undoubtedly a significant contributor to disability (Argyriou et al., 2014; Avan et al., 
2015), additional chronic effects and their importance cannot be dismissed. For 
example, pain and allodynia observed following OX (Kiernan, 2007; Fehrenbacher, 
2015) are suspected to result, not from neuropathy, but instead from sensory axon 
hyper-excitability (Park et al., 2009a, 2011b). Neither does neuropathy explain disability 
reported by patients for whom there is no evidence for a decrease either in SNAPs or in 
the density of epidermal nerve terminals (Burakgazi et al., 2011). When significant 
neuropathy does occur, it may not act alone in causing disability. Considering the 
possibility that OX affects proprioceptor signaling in patients, as we show here for 
rodents, we expect involvement of proprioceptors distributed throughout the body. 
Proprioceptors reside in trunk and proximal limbs muscles (Banks, 2006), and the 
sensory feedback they supply supports sundry movements and postures (Proske and 
Gandevia, 2009; Roden-Reynolds et al., 2015). Normal walking, for example, relies 
heavily on sensory feedback from proprioceptors in hip muscles (Roden-Reynolds et al., 
2015). Impaired signaling from those sites would be readily capable of contributing to 
imbalance, difficulty walking, and clumsiness variously described by OX patients. These 
proximal origins of movement disability originating proximally would be masked, 
however, and mistakenly assigned to proprioceptors in distal extremities denervated by 
length-dependent neuropathy, because we commonly interact with the environment 
through hands and feet. Sensation from the feet is critical for weight bearing activities 
(Meyer et al., 2004) and from hands for skilled grasping (Witney et al., 2004). All 
considered, it seems reasonable, and not disproven that factors in addition to distal 
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neuropathy contribute significantly to chronic disability. This notion could be critically 
assessed by discriminating tests for proprioceptive disorders in the trunk, shoulders and 
hips.  
 
A Mechanism for OX Modification of Proprioceptor Encoding  
 Several mechanisms apart from neuropathy might have resulted in selective 
modification of static firing by proprioceptors following OX treatment. Reduced static 
firing might have derived from one or another of the numerous specializations of muscle 
spindle receptors. For example, OX might have impaired static firing by reducing gamma 
motor drive to the spindle's intrafusal muscle fibers (Matthews, 1962; Boyd and Ward, 
1975; Banks et al., 1997). This possibility seemed unlikely, however, given our 
demonstration that complete experimental elimination of gamma motor input was not 
capable of significantly reducing proprioceptor responsiveness. More generally, we were 
able to rule out the necessity of specializations unique to muscle spindles by 
demonstrating that static responsiveness was equally impaired in Ib proprioceptors that 
provide the sole neural innervation to relatively non-specialized tendon organ receptors 
(Hunt, 1974; Jami, 1992; Zelena, 1994). The proprioceptors' parent axons, spanning the 
distance from muscle to dorsal roots, were fully competent to generate and conduct 
action potentials from nerve terminals to the spinal cord, even at sustained, high 
frequency in response to rapid oscillations in muscle length, i.e. vibrations. Finally, the 
generation of action potentials with high fidelity in response to each length oscillation 
throughout bouts of muscle vibration demonstrated that the underlying ionic currents 
generated either in mechano-transduction or in action potential encoding were not 
chronically disabled by OX (Bewick and Banks, 2015). Elimination of these mechanisms 
promoted the idea that abbreviated static responsiveness and increased threshold for 
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repetitive firing involved sustained ionic currents and channels normally generated 
during static and dynamic muscle stretch. The suspect channels are ones that contribute 
to currents underlying the receptor potential produced through mechano-transduction 
(Hunt et al., 1978) and/or currents required to sustain repetitive firing of action potentials 
for encoding steady depolarization.  
 The ion channels that support sustained repetitive firing during steady 
depolarization in muscle proprioceptors have not been identified. In numerous other 
neurons, repetitive firing to sustained and slow depolarization rests on properties of Na+ 
channels that inactivate slowly and thus generate persistent inward currents (NaPIC) 
(Crill, 1996; Lee and Heckman, 1998, 2001; Harvey et al., 2006a). One of these 
channels, NaV1.6 is expressed by large diameter DRG neurons (Black et al., 1996; 
Rush et al., 2007; Chung et al., 2015), which include muscle proprioceptors as well as 
primary sensory neurons supplying skin. Expression of NaV1.6 by the cell body is 
matched by expression in the nerve terminals of Merkel cells (Lesniak et al., 2014), 
which like proprioceptors are slowly adapting (Iggo and Muir, 1969; Zimmerman et al., 
2014). Furthermore, both NaV1.6 and NaPIC respond acutely to OX (Sittl et al., 2012). 
Collectively, these findings led us to predict that OX might abbreviate static 
responsiveness and increase the dynamic threshold of for repetitive firing by 
compromising NaPIC in the nerve terminals of proprioceptors.  
 We assessed the importance of NaPIC by testing whether a known 
pharmacologic antagonist would mimic the OX effect on static responsiveness and the 
dynamic threshold for repetitive firing. We selected riluzole for its action as a blocker of 
NaPIC (Benoit and Escande, 1991; Urbani and Belluzzi, 2000; Lamanauskas and Nistri, 
2008; Bellingham, 2011) in DRG neurons (Xie et al., 2011). Acute i.p. injection of riluzole 
in normal rats reproduced essentially all of the effects that chronic OX had or did not 
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have on proprioceptor encoding. While having no effect on the normal generation or 
conduction of action potentials evoked by muscle vibration, riluzole exhibited a dose 
dependent reduction in static responsiveness. Riluzole also increased repetitive firing 
threshold during slow ramps as it did in OX treated rats, and at higher doses increased 
repetitive firing threshold during fast ramps. These findings supported our hypothesis, 
however, riluzole's additional drug actions, e.g. activation of K+ current via BK channels 
(Grunnet et al., 2001; Wang et al., 2008) confound interpretation. Although there is as 
yet no more specific NaV1.6 antagonist, there is anti-epileptic drug, phenytoin, which 
shares only riluzole's block of NaPIC, but none of its other drug actions (Lampl et al., 
1998; Zeng et al., 2005). Previous study has established that in cats, phenytoin reduced 
the static responsiveness of muscle spindles (Anderson and Raines, 1974). Our finding 
that acute administration of phenytoin to normal rats also abbreviated static 
responsiveness bolsters the plausibility that NaPIC supports static firing in 
proprioceptors and that it may be the target of chronic OX.  
 The route by which chronic OX treatment might compromise NaPIC remains to 
be determined. Some studies (Sittl et al., 2012) though not all (Wu et al., 2009) 
demonstrate that OX acutely increases and prolongs NaPIC in DRG neurons. In 
addition, NaV1.6 provides a route through which mechanical allodynia develops, 
presumably from increased excitability of large diameter sensory neurons, within 24 h of 
intra-plantar injection of OX in mice (Deuis et al., 2014). These acute effects of OX are 
opposite to the decreased excitability we observe in muscle proprioceptors. We did find, 
however, that acute administration of high doses of OX produced spontaneous firing in 
normal rats, and we are currently testing whether this acute increase in excitability might 
trigger a compensatory and chronic decrease in excitability. If this is the case then 
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blocking acute hyper-excitability is a potential treatment that may prevent chronic effects 
on proprioception.  
 
Conclusion  
 Our findings demonstrate that oxaliplatin treatment has the potential to cause 
chronic movement disorders by a novel mechanism. In our rodent model of OX 
neurotoxicity, movement deficits in tasks relying on proprioception co-existed with 
impaired sensory encoding that selectively diminished the signal for static or slowly 
changing muscle position.  We suggest that proprioceptor signaling is diminished by a 
chronic effect of OX that impairs NaPIC.  Identification of this independent target of OX 
neurotoxicity offers a novel target for therapeutic intervention.
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Fig. 3.  Movement disability in OX-treated rats.  Rats were scored for errors in hind 
foot placement while walking on unevenly spaced ladder rungs in sessions spanning 11 
weeks. (A, C) For untreated control rats (n=5) data were pooled and plotted as percent 
change in order to illustrate improvement (training effect) relative to initial task sessions 
(time 0); mean values (open black circles joined by lines) are bracketed for 95% 
confidence interval (CI).  For each one of 10 OX-treated rats (identified by red number) 
mean percent change is plotted per task session, and the schedule for OX injection is 
noted by blue dots. (A) Secure hind foot placement was scored by errors/steps in rung 
contact multiplied by -1 and computed as percent change from the pre-treatment value 
for each OX treated rat. (B) Photograph shows left hind limb slip in double image 
(simultaneous side and underneath views) of OX-treated rat walking on ladder rungs. (C) 
Correct hind foot placement was scored by errors/steps in correctly placing the trailing 
hind foot on the same rung as the ipsilateral forelimb multiplied by -1 and computed as 
percent change from the pre-treatment value for each OX treated rat.  (D) Plot of secure 
vs. correct hind foot placement (unlike Figs. 1A and 1C, values were calculated as 
percent change from untreated control mean value at week 11); box at origin 
encompasses variation pooled for untreated control rats.   
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Fig. 4. OX treatment shortens firing duration during static muscle stretch. 
Representative records of Ia muscle spindle afferents firing (grey traces show intra-
axonal records of action potentials, black dots indicate instantaneous firing rate) in 
response to ramp-hold-release muscle stretch (B bottom trace; 3 mm, 20 mm/s, 1 s hold 
phase). (A) In an untreated control rat, Ia fired during fast-dynamic (ramp) phase and 
throughout static (hold) phase of stretch. (B) In a rat 4 weeks after 8-week treatment 
course of OX, Ia fired similar to normal during fast- dynamic phase but stopped firing 
during the static phase of muscle stretch. (C) For the same Ia muscle spindle afferent as 
in B, vibration superimposed on muscle stretch (bottom trace; 100 Hz, 80 µm vibration 
during stretch hold phase) restored firing. (D) Mean± SE for duration of static-phase 
firing expressed as percent change for pooled samples of Ia muscle spindle afferents in 
OX-treated rats (71 Ia's in 10 rats) relative to control rats (52 Ia's in 5 rats). (E) 
Comparison of mean static-phase firing (n > 4 Ia muscle spindle afferents per animal) 
and secure hind foot placement for individual control (C) and OX (OX) animals 
expressed as a percent change from mean control values. Secure hind foot placement 
during horizontal ladder rung task is positively correlated with the duration of static 
responsiveness (r2 = 0.76, p < 0.01, dashed line).  
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Fig. 5. OX-treatment increases repetitive firing threshold during slow- but not fast- 
dynamic muscle stretch. Threshold for repetitive firing was measured from Ia muscle 
spindle afferents during fast ramps (20 mm/s; left column) and slow ramps (4 mm/s in 3 
successive triangular stretches; right column). Action potential firing and firing rate in 
response to muscle stretch (traces described in Fig. 4) were taken from one Ia muscle 
spindle afferent in a control rat (A) and one in an OX-treated rat (B). Repetitive firing 
threshold (arrow heads) after OX-treatment was similar to control for fast ramps, but 
higher than control for slow ramps. Note that threshold of the transient initial burst was 
unchanged. (C) Mean ± SE for repetitive firing threshold for fast (left) and slow (right) 
ramps expressed as percent change for pooled samples of Ia muscle spindle afferents in 
OX- treated rats (58 Ia's in 10 rats) relative to control rats (51 Ia's in 5 rats). 
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Fig. 6. Riluzole mimics OX-treatment in shortening firing duration during static 
muscle stretch.  Representative records (as described in Fig. 4) of Ia muscle spindle 
afferent responses to muscle stretch in one rat studied (A) before and (B) after Riluzole 
injection (6 mg/ kg i.p.). Similar to the effect of OX-treatment (Fig. 4), acute Riluzole 
injection shortened static responsiveness, but had no apparent effect on dynamic 
responsiveness exhibited during fast-ramp stretch or vibration (C). (D) Reduction in 
duration of static responsiveness (expressed as percent change from control) for Ia 
muscle spindle afferents was dose dependent. 
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Table 1.  Muscle length encoding by Ia muscle spindle afferents. Rats in oxaliplatin 
(OX) study were all subject to the same procedures, i.e. chronic measurement of motor 
performance and terminal measurement of proprioceptor encoding; 10 received 
repeated injections of vehicle + OX and 5 received injections of vehicle alone. All rats in 
riluzole (Ril) study, were examined only in terminal experiments to obtain measurement 
of proprioceptor encoding before and after Ril injection.  n, number of afferents pooled 
within groups.  Nested ANOVA and Tukey’s post hoc tests were used to test for the 
significance of group differences. * P < 0.05 
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Fig. 7. Riluzole mimics the OX-treatment increase in repetitive-firing threshold 
during slow-dynamic muscle stretch. Representative records of Ia muscle spindle 
afferent firing in response to muscle stretch (cf. Fig. 3) in a rat studied (A) before and (B) 
after riluzole injection (6 mg/kg i.p.). Repetitive firing threshold (arrow heads) was similar 
before and after acute Ril injection for fast ramps, but was substantially higher for slow 
ramps. Note that threshold of the transient initial burst was unchanged. (C) Mean ± SE 
repetitive firing threshold for fast (left) and slow (right) ramps expressed as percent 
change for pooled samples of Ia muscle spindle afferents after relative to before Ril-
injection. 
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Fig. 8. Phenytoin shortens firing duration during static muscle stretch. (A) 
Representative records of a Ia muscle spindle afferent firing (top grey trace action 
potentials with instantaneous firing rate indicated by superimposed black dots) in 
response to ramp-hold-release muscle stretch (bottom trace; 3 mm, 20 mm/s, 1 s hold 
phase) following phenytoin injection (20 mg/kg i.p.). Similar to the acute effect of riluzole 
(cf Fig. 4), acute phenytoin injection shortened static responsiveness, but had little effect 
on dynamic responsiveness exhibited during fast-ramp stretch or vibration (data not 
shown). (B) Duration of static responsiveness (expressed as percent change from 
control) significantly reduced for 25 Ia muscle spindle afferents measured in rats injected 
with phenytoin compared with 21 Ia muscle spindle afferents in control rats. 
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Fig. 9. Effects of OX treatment and riluzole on group II spindle and Ib tendon-
organ proprioceptors. (A) OX treatment shortened firing duration during static muscle 
stretch nominally for II's (p = 0.077) and significantly for Ib's. (B) Acute riluzole injection 
also tended to shorten firing at the highest doses 
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Chapter V 
 
Specific Aim 2: To test the hypothesis that 5-HT2 agonists, that increase 
persistent inward currents, can restore sensory encoding by muscle 
proprioceptors following OX. 
 
Introduction 
  
 Aim one establishes that chronic OX impairs a NaPIC necessary for sustained 
repetitive firing during normal proprioceptor encoding.  This current localizes to the 
receptor terminal and offers a novel therapeutic target to restore proprioceptor encoding.  
Recent work has identified the Na+ channel subtypes present at the sensory nerve 
terminal.  Consistent with NaPIC playing a role in encoding, NaV 1.6 has been identified 
at the sensory nerve terminal of muscle proprioceptors (Carrasco et al., 2017).  NaV 1.6 
has been shown in large diameter dorsal root ganglion neurons to mediate a large 
NaPIC, suggesting that it may be performing a similar task at the sensory nerve terminal 
(Rush et al., 2007).  Targeting this current might restore repetitive firing lost in muscle 
proprioceptors following OX. 
 NaPIC’s role in repetitive firing has been well established in numerous types of 
neurons (Crill, 1996; Lee and Heckman, 2001; Harvey et al., 2006a; Perrier et al., 2013). 
The subthreshold NaPIC is thought to arise from the same transient Na+ channels that 
underlie action potentials (Alzheimer et al., 1993).  The majority of voltage-gated Na+ 
channels carrying the transient Na+ current underlying action potentials rapidly inactivate
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after an opening period.  A small number of these channels likely 1-3% enter a 
persistent state, giving rise to NaPIC (Alzheimer et al., 1993).   
 In motoneurons, 5-HT and serotonergic agonists increase the amplitude of 
NaPIC (Harvey et al., 2006b; Murray et al., 2010; Murray et al., 2011).  5-HT2 receptor 
activation in motoneurons that are unable to repetitively fire during slow current injection 
led to robust repetitive firing that correlated with large increases in NaPIC (Harvey et al., 
2006b).   5-HT2 receptors are coupled to the Gαq-protein, which through activation of 
phospholipase C, increases DAG, and IP3(Harvey et al., 2006b; Murray et al., 2011).  
PKC is known to phosphorylate Na+ channels altering their activation and inactivation.  
Furthermore, PKC has been show to facilitate NaPIC ((Franceschetti et al., 2000).   
 In order to determine the feasibility of therapeutic restoration of proprioceptor 
encoding, a non-specific 5HT-2 receptor agonist quipazine was chosen (Chopek et al., 
2013).  Quipazine was given in terminal experiments following injection with 6 mg/kg 
riluzole.  In the acute setting quipazine improved proprioceptor encoding, this suggested 
that encoding following OX could be restored.  Following chronic OX treatment, a FDA 
approved 5-HT2C receptor agonist (Witkamp, 2011), lorcaserin was tested.  The switch 
to lorcaserin was necessary to establish the potential for translation to human studies 
with an FDA approved drug.   
 
Methods 
 
 All surgical procedures and data collection in this aim are the same as the 
studies outlined above in general methods and specific aim 1 methods.   
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Acute Pharmacological Studies 
 Rats previously untreated were used to measure proprioceptor responses in 
terminal experiments as described in general methods. Ten animals were used to 
assess the effects of quipazine on muscle proprioceptors impaired by riluzole.  In these 
animals muscle proprioceptors were sampled before and after i.p. injection of riluzole (6 
mg/kg), followed by sampling after i.p. injection of quipazine (10 mg/kg).  In five of these 
animals ventral roots were sectioned prior to any recording to remove any influence of 
gamma motoneurons on muscle spindle function.  Riluzole injections were handled as 
described in aim 1.  Quipazine, 10mg, was dissolved in 1 ml DMSO and 4 ml 0.9% 
saline and dose by animal body weight (mg/kg).   
 
Chronic OX Studies  
 In the same animals that underwent chronic OX treatment in specific aim 1, three 
animals were selected for further study with lorcaserin.  Muscle proprioceptors were 
sampled prior to i.p. injection with lorcaserin, 2 mg/kg.  Lorcaserin, 10 mg, was dissolved 
in 0.9% normal saline and was dosed based on animal body weight (mg/kg).  Following 
collection of muscle proprioceptor responses following lorcaserin, ventral roots were 
sectioned and sampling continued.    
 
Results 
 
 Chronic OX impairs muscle proprioceptor encoding by disrupting a novel NaPIC, 
leading to behavioral deficits.  Identification of this underlying mechanism allows for 
application of a targeted therapeutic to potentially restore muscle proprioceptor encoding 
and behavior.  If successful in the rodent, this therapeutic would have the potential to 
translate to human studies and significantly improve patient lives. 
 
 
64 
 
Quipazine restores Ia muscle spindle afferent responsiveness after riluzole 
 In other neuronal subtypes, NaPIC can be increased by activation of 5-HT2 
receptors.  We applied two different 5-HT2 receptor agonists after either acute riluzole or 
chronic OX.  In the acute study, a dose of 6mg/kg riluzole was chosen because it most 
closely matches the effects of chronic OX on muscle proprioceptor encoding, specifically 
Ia muscle spindle afferents.  Following acute injection of 6 mg/kg riluzole 68% of 
sampled 1a muscle spindle afferents fail to fire at least 800 ms of a 1000 ms hold phase, 
compared to only 25% in control conditions.  This drastic loss of sustained repetitive 
firing represents a significant loss of muscle length and force feedback to the central 
nervous system.   
 Within individual animals treated with riluzole, quipazine dramatically improved 
repetitive firing in Ia muscle spindle afferents.    Fig. 9 compares static responsiveness 
duration for control, 6 mg/kg riluzole, and 10 mg/kg quipazine.  Riluzole (6 mg/kg) 
significantly reduces sustained firing, and following i.p. injection of quipazine there is a 
significant (p<0.05) increase in static responsiveness.  After quipazine, only 33% of Ia 
muscle spindle afferents failed to fire at least 80% through the hold phase, compared to 
68% in riluzole 6 mg/kg.  This marks a significant restoration of sustained repetitive firing 
during static muscle stretch and therefore fixed muscle position and force feedback to 
the central nervous system.  This effect was rapid and occurred within 45 min of injection 
and lasted for hours following injection. 
 Quipazine’s ability to increase the duration of static responsiveness restores part 
of the signal lost following treatment with riluzole.  Characteristic of disrupting NaPIC, 
riluzole also selectively disrupts repetitive firing during slow dynamic stretch, measured 
by an increase in the repetitive firing threshold (slow dynamic threshold).  Similar to 
impaired repetitive firing during sustained muscle stretch, the loss of repetitive firing 
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during muscle stretch represents a significant loss of feedback regarding changing 
muscle length and force to the central nervous system.   Fig. 10 compares slow dynamic 
threshold in control rats, and those treated with riluzole and quipazine.  The increase in 
slow dynamic threshold by riluzole was corrected by quipazine.  In fact quipazine 
reduced slow dynamic threshold to less than that observed in controls.  Thus, quipazine 
increased repetitive firing deficits during slow muscle stretch, restoring the lost feedback 
to the central nervous system. 
 
Lorcaserin Restores Ia Muscle Spindle Afferent Responsiveness after OX 
 Similar to riluzole (6 mg/kg), following chronic OX 73% of Ia muscle spindle 
afferents sampled failed to fire at least 800 ms during a 1000 ms hold phase.  The 
similar effects of riluzole and chronic OX on static responsiveness suggest that 
quipazine or other 5-HT2 agonists should restore firing following chronic OX.  Due to the 
translational implications of restoring proprioceptor encoding following chronic OX, the 
FDA approved 5-HT2C receptor agonist lorcaserin was chosen (Witkamp, 2011). Fig. 11 
shows the effects of lorcaserin on the duration of static responsiveness.  Similar to 
quipazine, lorcaserin (2 mg/kg) significantly increased the duration of static 
responsiveness.  After lorcaserin only 40% of Ia muscle spindle afferents failed to fire at 
least 800 ms during a 1000 ms hold phase.  The effect was not as robust as the 5-HT2 
nonspecific agonist quipazine given in the acute setting with riluzole, but was still 
capable of restoring a significant amount of encoding and therefore muscle length and 
force feedback after chronic OX.   
 In order for lorcaserin to have potential as a target treatment following OX it 
should also significantly reduce the slow dynamic threshold.  Fig. 12 compares the slow 
dynamic threshold in control, OX, and following lorcaserin.  Fig. 12A is a representative 
record following chronic OX increasing the slow dynamic threshold.  Fig. 12 B is from the 
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same animal following injection with lorcaserin (2 mg/kg), and shows the reduction in 
slow dynamic threshold.  Again, the results with lorcaserin were not as robust as those 
with riluzole, but clearly showed a significant effect on slow dynamic threshold following 
OX.   
 Our conclusions from aim 1 suggest that chronic OX is most likely disrupting a 
NaPIC necessary for muscle proprioceptor encoding.  The presence of NaPIC in muscle 
proprioceptors is novel and any regulation at this level is unknown.  NaPIC in other 
neuronal systems is regulated by Gq-coupled 5-HT2 receptors (Harvey et al., 2006b; 
Murray et al., 2011).  The next step is to determine how quipazine and lorcaserin are 
working to restore encoding specifically in Ia muscle spindle afferents.  There are two 
potential locations where these drugs could be working, either peripherally at the spindle 
terminal, or centrally likely by increasing output from gamma motoneurons.  As 
mentioned in the background section, muscle spindles receive both sensory and motor 
innervation.  The motor innervation arises from gamma motoneurons, which can be 
further broken down in to static and dynamic, based on their effects on either static or 
dynamic responsiveness (Boyd and Ward, 1975; Banks et al., 1997).  
 In order to determine where quipazine and lorcaserin were acting to restore 
encoding, ventral roots were sectioned either prior to any recording in the case of 
riluzole or following injection of the 5-HT2 agonists in the case of chronic OX.  If the 
selected 5-HT2 agonists are working peripherally, then ventral root section should have 
no effect on their ability to restore encoding.   If they are working centrally, ventral root 
section should eliminate their effects.   
 Fig. 13 shows the effects of ventral root section on the effectiveness of quipazine 
and lorcaserin to increase the duration of static responsiveness.  Note, that in the case 
of quipazine, ventral roots were sectioned prior to any recording and riluzole injection.  
As discussed in aim 1 ventral root section had no effect on encoding in control or riluzole 
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treated afferents.  In OX animals ventral roots were sectioned following injection and 
data collection with lorcaserin.  In the case of riluzole and quipazine (Fig. 13A) ventral 
root section eliminates the efficacy of quipazine to restore static encoding.  With 
lorcaserin (Fig. 13B) the trend is similar, but did not reach significance.  This is likely 
because the effectiveness of lorcaserin to restore static responsiveness was less than 
that of quipazine, however a peripheral effect of lorcaserin cannot be ruled out.   
 Ventral root section showed similar effects on slow dynamic threshold following 
5-HT2 agonist injection.  Acutely, eliminating motor influence significantly reversed the 
effectiveness of quipazine to decrease the slow dynamic threshold.  The same results 
were observed with ventral root section after lorcaserin.  Unlike the effects of ventral root 
section on static responsiveness, ventral root section after lorcaserin significantly 
increased slow dynamic threshold.  This difference most likely arises from the fact that 
lorcaserin had a larger effect on slow dynamic threshold than the duration of static 
responsiveness.  
 
Discussion 
 
  
 Disruption of NaPIC by chronic OX significantly impairs muscle proprioceptor 
encoding resulting in behavioral deficits.  The largest effect was on Ia muscle spindle 
afferents, and so in aim two, known 5-HT2 receptor activators were applied.  In the acute 
setting following riluzole and after chronic OX 5-HT2 agonists significantly increased 
repetitive firing and were able to restore encoding in Ia muscle spindle afferents.  Overall 
lorcaserin was less effective in restoring proprioceptor function.  This may result from 
lorcaserin being a specific activator of 5-HT2C receptors, whereas quipazine is non-
specific.  Ventral root section eliminated the effects of 5-HT2 receptor agonists on 
impaired muscle proprioceptors encoding, suggesting that their actions were central.    
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Localizing the Actions of Quipazine and Lorcaserin 
   Results following ventral root section point to a central mechanism for quipazine 
and lorcaserin.  The most likely explanation is that quipazine and lorcaserin increased 
output from gamma motoneurons, which extrinsically modulate muscle spindle afferent 
discharge (see section II).  The effectiveness of both drugs to restore dynamic and static 
responsiveness suggests that they increased output from both static and dynamic 
gamma motoneurons.    
 Gamma motoneurons are smaller than alpha motorneurons, which in part 
explains their different membrane properties (Jankowska et al., 1998; Enjin et al., 2012).  
Despite these differences gamma motoneurons show similar firing frequencies when 
compared to alpha motoneurons (Jankowska et al., 1998; Enjin et al., 2012).  Given that 
gamma motoneurons must generate repetitive trains of action potentials like alpha 
motoneurons, it is likely that they express voltage-gated Na+ channels that carry a 
NaPIC.  It is likely that NaPIC in gamma motoneurons is also modulated by 5-HT2 
receptors.   
 5-HT1D has been identified as a novel marker for gamma motorneurons (Enjin et 
al., 2012), but there is no available data on the expression of 5-HT2 receptors.  Previous 
studies have established that serotonin precursors (5-HTP) increase firing in gamma 
motoneurons (Ellaway and Trott, 1975; Myslinski and Anderson, 1978; Djupsjobacka et 
al., 1995; Jankowska et al., 1998), suggesting that serotonin receptors increase their 
output.  This occurs in two different ways, by directly activating 5-HT receptors on 
gamma motoneurons and/or by reflex activation of gamma motoneurons mediated most 
likely by chemosensitive group III and IV muscle afferents (Djupsjobacka et al., 1995).  
Based on the similarities of alpha and gamma motoneurons 5-HT2 agonists likely 
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increase output by increasing PIC. Although the exact mechanism of gamma 
motoneuron activation by quipazine and lorcaserin is not discernable based on our 
results, they significantly improve muscle proprioceptor encoding impaired by riluzole 
and OX.             
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
Functional Considerations 
 Gamma motoneuron input modulates muscle proprioceptor output in a task 
dependent manner (Prochazka and Ellaway, 2012). There several different supported 
theories of how and when gamma motoneurons fire during movement: alpha-gamma co-
activation, tonic- phasic gamma activation, fusimotor set, and forward sensory models 
(Taylor et al., 2006; Prochazka and Ellaway, 2012; Ellaway et al., 2015).  Evidence for 
all of these theories have been identified in both animal and human studies.  As 
described by its name alpha-gamma co-activation occurs when gamma motoneurons 
are activated in sync with alpha motoneurons.  In this model gamma firing keeps the 
muscle spindles in a sensitive state to detect unexpected length changes, evidence for 
which has been found using microneurography (Burke et al., 1978; Aniss et al., 1990; 
Murphy and Martin, 1993; Kakuda et al., 1996).  Other studies in cats favored a tonic 
phasic activation of gamma motoneurons.  In this model static gamma motoneuron 
discharge is relatively tonic suggesting that group II afferent firing was a temporal 
template of the intended movement, while dynamic gamma discharge is phasic and 
occurs just prior to the transition from muscle shortening to lengthening (Taylor et al., 
2000b; Taylor et al., 2000a; Taylor et al., 2006).  This would sensitize Ia muscle spindle 
afferents to the beginning of muscle stretch. Similar to tonic- phasic gamma activation, 
fusimotor set suggests that there is tonic firing from static gamma motoneuron and that 
dynamic gamma activity was modulated in an activity dependent manner (Prochazka et 
al., 1985).  Lastly forward sensory models are a recent development based on 
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microneurography in humans that showed that muscle spindle firing reflected muscle 
length changes, muscle contraction, and was predictive of future movements (Dimitriou 
and Edin, 2010).  The wide variety of evidence for gamma motoneuron function 
suggests that their output to muscle spindles is linked with activation of alpha 
motoneurons, and dependent on the motor task (Prochazka and Ellaway, 2012).   
 Given the large functional impact on muscle spindle output, gamma motoneuron 
discharge may be able to compensate for impaired encoding following OX.  This idea is 
supported by our results above, which suggest that increased gamma motoneuron 
output compensates for the encoding deficit following OX.  However, this result is 
complicated by the fact that in our in vivo preparation, gamma motoneuron output is 
suppressed by anesthesia (Matthews, 1963; Haftel et al., 2004).  It is evident from aim 1 
that suppressed or eliminated gamma motoneuron input is not responsible for the 
impaired encoding deficit following OX.  It may be possible however that the encoding 
deficit we observe would not be present in awake freely moving animals because of 
intact and physiologic gamma motoneuron output.  Following chronic OX animals 
showed significant behavioral deficit and the severity of behavioral deficit was highly 
correlated with the amount of impaired encoding.   This suggests that either normal 
gamma motoneuron output is not able to compensate for impaired encoding, or chronic 
OX also impairs repetitive firing in motoneurons.  Regardless of which of these is the 
case, both would be significantly improved by increasing NaPIC and therefore repetitive 
firing.    
 While direct study of motorneurons following OX has not been done, recent 
clinical studies have highlighted motor deficits in patients following chronic OX.  For 
example, following OX patients describe that their “legs feel heavy, like pulling a couple 
of logs around” (Bennett et al., 2012).  These testimonials are corroborated by other 
studies describing fatigue and increased fall risk in patients following OX (Burakgazi et 
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al., 2011; Tofthagen et al., 2012; Kneis et al., 2015; Taleb et al., 2017).  This may result 
from impaired motoneuron firing, potentially due to a decrease in NaPIC.  Reduced 
NaPIC in motoneurons has been shown to be an important contributor to weakness and 
fatigue following sepsis (Nardelli et al., 2016).  If alpha motoneuron repetitive firing is 
disrupted following chronic OX, then it is possible that gamma motoneurons may be 
similarly affected.  An effect on gamma motoneurons would compound muscle spindle 
dysfunction.  This suggests that lorcaserin could potentially restore muscle spindle 
feedback and alleviate weakness and fatigue following chronic OX.  
 
Optimal Therapeutic Target   
 Results from aim 1 identified an encoding problem intrinsic to muscle 
proprioceptors that as shown above, can be fixed by extrinsically likely by increasing 
gamma motoneuron discharge.  As discussed above patients also have motor 
symptoms following OX, suggesting that there might be a problem intrinsic to the 
motoneurons.  Preliminary studies from our laboratory support the idea that following 
chronic OX motoneurons also have trouble repetitively firing (data not shown).  This 
finding is similar to that in motorneurons following sepsis, which is thought to result from 
decreased NaPIC (Nardelli et al., 2016).  While 5-HT2 agonists would likely correct this 
issue, which then as suggested by results in this aim would restore encoding in muscle 
proprioceptors, a more effective treatment would be to target NaPIC in each location.  As 
mentioned regulation of NaPIC within muscle proprioceptors is unknown, but previous 
studies have shown the 5-HTP increases the output from muscle spindles that have 
been de-efferented by ventral root section (Ellaway and Trott, 1975).  This suggests that 
serotonin through an unknown receptor can modulate muscle spindle output 
peripherally.  Future studies are needed to identify and characterize modulation of 
NaPIC in muscle proprioceptors. 
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Conclusion 
 
 Results with riluzole in aim one establishes that impaired encoding intrinsic to 
muscle proprioceptors following chronic OX likely results from disrupted NaPIC.  
Application of 5-HT2 receptor agonists, quipazine and lorcaserin, which are known to 
increase NaPIC, significantly restored muscle proprioceptor encoding following riluzole 
and chronic OX respectively.  Ventral root section determined that these 5-HT2 agonist 
likely restored encoding by increasing gamma motoneuron output.    
 While the restoration of Ia muscle spindle encoding occurred indirectly by gamma 
motoneuron activation, there is evidence to suggest that motoneuron function may also 
be disrupted following chronic OX (Burakgazi et al., 2011; Tofthagen et al., 2012; Kneis 
et al., 2015; Taleb et al., 2017).  This suggests that disruption of NaPIC following chronic 
OX may extend beyond muscle proprioceptors and may help account for fatigue and 
weakness experienced by patients. Regardless of the exact mechanism, the 
effectiveness of 5-HT2 agonists at restoring encoding suggest that they could 
significantly improve behavioral deficits in animal and alleviate proprioceptive deficits in 
patients.    
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Fig. 10. 5-HT2 receptor agonist, quipazine significantly increase the duration of 
static responsiveness following 6 mg/kg riluzole.  (A,B) Representative traces of 
action potential firing (gray lines) with instantaneous firing rates (black dots) in response 
to muscle stretch (A,B bottom trace; 3mm 20 mm/s). (A) Acute injection of riluzole (6 
mg/kg) reduced the duration of static responsiveness in Ia muscle spindle afferents. (B) 
In the same animal, injection of quipazine (10 mg/kg) restored static responsiveness in 
Ia muscle spindle afferents.  (C)  Mean ±SE for duration for static responsiveness in Ia 
muscle spindle afferents in various treatment conditions.  
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Fig. 11.  Fig. 10.  5-HT2 receptor agonist, quipazine significantly decreased slow 
dynamic threshold following riluzole 6 mg/kg. (A,B) Representative records of action 
potential firing (gray lines) with instantaneous firing rates (black dots) in response to 
ramp-hold-release muscle stretch (A,B bottom trace; 3mm 4 mm/s, 1 s hold phase).  (A) 
Injection of riluzole (6 mg/kg) increased the slow dynamic threshold (arrowheads) in Ia 
muscle spindle afferents.  (B) In the same animal, injection of quipazine (10 mg/kg) 
reduced the slow dynamic threshold (arrowheads) in Ia muscle spindle afferents.  (C) 
Mean ± SE for duration for slow dynamic threshold in Ia muscle spindle afferents in 
various treatment conditions.    
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Fig. 12.  5-HT2C receptor agonist, lorcaserin significantly increase the duration of 
static responsiveness following chronic OX.  (A,B) Representative traces of action 
potential firing (gray lines) with instantaneous firing rates (black dots) in response to 
muscle stretch (A,B bottom trace; 3mm 20 mm/s). (A) Chronic OX reduced the duration 
of static responsiveness in Ia muscle spindle afferents. (B) In the same animal, injection 
of lorcaserin (2 mg/kg) restored static responsiveness in Ia muscle spindle afferents. (C)  
Mean ±SE for duration for static responsiveness in Ia muscle spindle afferents in various 
treatment conditions.   
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Fig. 13.  5-HT2C receptor agonist, lorcaserin significantly decreased slow dynamic 
threshold following chronic OX. (A,B) Representative records of action potential firing 
(gray lines) with instantaneous firing rates (black dots) in response to ramp-hold-release 
muscle stretch (A,B bottom trace; 3mm 4 mm/s, 1 s hold phase).  (A) Chronic OX 
increased the slow dynamic threshold (arrowheads) in Ia muscle spindle afferents.  (B) 
In the same animal, injection of lorcaserin (2 mg/kg) reduced the slow dynamic threshold 
(arrowheads) in Ia muscle spindle afferents.  (C) Mean ±SE for duration for slow 
dynamic threshold in Ia muscle spindle afferents in various treatment conditions. 
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Fig. 14.  Ventral root section eliminated the effects of quipazine or lorcaserin on 
static responsiveness (A, B) and slow dynamic threshold (C,D).   (A-D) Mean ±SE 
for duration for static responsiveness and slow dynamic threshold in Ia muscle spindle 
afferents following quipazine (A,C) or lorcaserin (B,D) before and after ventral section.  
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Chapter VI 
Specific Aim 3:  To determine if spontaneous activity following acute OX in 
muscle proprioceptors arises from sensory nerve terminals  
 
 
Introduction 
 
 Neurotoxic side effects of the highly effective chemotherapy agent, oxaliplatin 
(OX) limit its clinical efficacy.  OX is commonly used as an adjuvant to surgical tumor 
removal, and significantly improves five-year survival rates (Andre et al., 2009). However 
during and following cessation of treatment patients are burdened with debilitating 
neurotoxicity, which significantly diminishes quality of life.  Within hours and for days 
following OX infusion, greater than 90% of patients experience abnormal sensations 
(paresthesia), pain (dysesthesia), muscle spasm and fasciculation, and cold induced 
allodynia.  (Argyriou et al., 2008; Argyriou et al., 2014).  These positive symptoms 
typically last less than one week, but re-occur and often worsen following every infusion 
(Park et al., 2013).  The common mechanism underlying these symptoms are changes 
in the excitability of sensory and motor axons (Adelsberger et al., 2000; Wilson et al., 
2002; Lehky et al., 2004; Krishnan et al., 2005; Benoit et al., 2006; Krishnan et al., 2006; 
Park et al., 2011b; Park et al., 2012a; Argyriou et al., 2013a).  Conversely, accumulating 
doses of OX result in chronic negative symptoms including numbness and tingling in the 
toes and the feet, as well as sensory ataxia associated with poor balance and increased 
risk for falls (Beijers et al., 2014; Briani et al., 2014; Cavaletti, 2014; Avan et al., 2015).
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These symptoms are thought to arise from a length dependent neuropathy (Beijers et 
al., 2014; Briani et al., 2014; Cavaletti, 2014; Avan et al., 2015), however recent studies 
have identified deficits in patients with no signs of neuropathy (Burakgazi et al., 2011).  
Unlike the transient effects of acute OX, these symptoms persist with little improvement 
years after drug cessation (Park et al., 2011a).  It is unknown if there is a causal link 
between the acute and chronic syndromes associated with OX chemotherapy, but 
evidence shows a correlation between the severity of acute symptoms and the 
development of chronic impairment (park 2009, Krishnan et al. 2006; Park et al. 2009b), 
The positive symptoms following acute OX administration are commonly attributed 
increased excitability in sensory and motor axons, caused by changes in voltage-gated 
ion channels.  For example, in vitro and in vivo studies of acute OX have shown changes 
in voltage-gated Na+ channels, including hyperpolarized shifts in their activation and 
inactivation (Adelsberger et al., 2000; Grolleau et al., 2001; Benoit et al., 2006).  Studies 
in patients have used threshold tracking techniques to suggest changes in voltage-gated 
Na+ channels (Krishnan et al., 2006; Park et al., 2011b).  The converging conclusion 
from these studies is that OX is affecting the transient voltage gated Na+ channels 
distributed throughout sensory and motor axons, resulting in the positive symptoms 
experienced by patients.   
 Recent studies provide insight into the proposed link between acute and chronic 
OX neurotoxicity.  For example, genetic studies in patients have identified specific 
polymorphisms in the voltage-gated Na+ channel gene correlated with the severity of the 
acute and chronic syndrome (Argyriou et al., 2013b).  Aim 1 of this dissertation identified 
that OX disrupts specific voltage-gated Na+ channels in muscle proprioceptors leading to 
impaired sensory encoding and behavior.  That aim demonstrated that following a 
clinically relevant dosage regime of OX muscle proprioceptors displayed impaired 
sensory encoding; specifically they were unable to maintain repetitive firing.  Further 
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investigation of these changes showed that this encoding deficit resulted from disruption 
of a subtype of voltage-gated Na+ current (persistent inward Na current) most likely 
located in the sensory nerve terminal.  NaV 1.6, which is known to mediate a NaPIC 
localizes to the sensory terminal in muscle proprioceptors (Carrasco et al., 2017). This 
finding suggests that in addition to the dorsal root ganglion, OX may cause changes in 
the distal endings of sensory nerves.  If acute hyper-excitability following OX is linked to 
the chronic loss of excitability, then there may be changes within the sensory nerve 
terminal following OX infusion.  
 The purpose of this study was to localize the changes following acute OX that 
are responsible for the positive symptoms experienced by patients.  We applied in vivo 
electrophysiological techniques to localize changes in excitability following acute OX 
administration.  Our in vivo rat model shows all of the signs of acute OX neurotoxicity 
including spontaneous activity in sensory axons, and muscle fasciculation with 
corresponding repetitive EMG bursting similar to that observed in patients.  Following 
acute OX injection we tested the excitability of individual sensory axons and applied 
novel spike triggered averaging techniques to localize the origin of spontaneous firing in 
sensory axons and EMG bursting. 
 
Methods 
 
Acute OX Studies 
 These studies were designed to test effects of acute OX treatment on sensory 
and motoneurons. Oxaliplatin, (BIOTANG, Lexington, MA) dissolved in 5% dextrose was 
administered via intraperitoneal (IP) injection one day prior to terminal experiments.  Two 
different dosages were used in this study 20, or 30 mg/kg.  The higher dose increased 
the proportion of spontaneous activity available for STA analysis.  Spontaneous sensory 
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and motor activity was observed, and STA analysis produced the same result at the 20 
mg/kg dose.  
 
Recording Preparation/ Data Collection 
 In order to sample muscle proprioceptors, dorsal roots were isolated and placed 
on bipolar recording hook electrodes.  Rootlets were tested for orthodromic action 
potential volley, and stretch sensitive activity.  Within dorsal rootlets individual sensory 
axons were penetrated with sharp glass microelectrodes filled with 2M K+ Acetate-.  
Sensory axons were randomly sampled and selected for recording when they displayed 
orthodromic action potentials with a conduction delay of < 3 ms following peripheral 
electrical stimulation of triceps surae nerves.  During spike triggered averaging 
experiments ventral roots were placed in continuity with bipolar electrodes for recording 
or stimulation to obtain the latency of the compound muscle action potential (CMAP).    
 
Measurements of Axonal Excitability 
 As described above, individual sensory axons were impaled and identified based 
on orthodromic action potentials in response to stimulation of the Mg/LgS nerves.  
Techniques described below are the same as those previously used to measure axon 
parameters (Novak et al. 2009).  For the purposes of this study excitability measures 
were only assess from group Ia and Ib muscle proprioceptors.  When membrane 
potential was -40 mV or less and action potential amplitude was ≥ 40 mV measurements 
of axon properties were recorded.  Depolarizing, 1 ms current pulses injected every 
second at increments of 0.1 nA were used to determine rheobase current (the current 
that triggered action potentials).  Hyperpolarizing of the same duration and frequency at 
1-3 nA was used to determine input resistance and to evoke action potentials at anode 
break.  Intra-axonal records of action potentials, membrane potential, current injection, 
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and muscle length and force changes were digitized (20 kHz), and stored on a computer 
for later analysis using Spike2 software. 
 Measurements of threshold for action potentials and amplitude were made by 
manually placing cursors in Spike2 at point of inflection during the rising phase of the 
action potential, and at its peak.  The amplitude of the action potential was calculated as 
the different between the membrane potential and the potential at the peak of the action 
potential.  In order to determine the maximal rate of rise during the action potential (max 
DV/DT), the first derivative of the action potential was taken within Spike2.  Lastly, 
threshold was determined as the difference between the potential at which DV/DT was 
equal to 100 and the resting membrane potential. 
 
Spike Triggered Averaging 
  Spike triggered averaging techniques (STA) were used to assess the origin of 
spontaneous firing from muscle proprioceptors following OX.  These techniques have 
been previously described for use in motoneurons, but the principles used here are 
identical (Bullinger et al., 2011a).  Intra-axonal records of spontaneous and mechanically 
evoked action potentials from sensory axons was used to trigger an average from a 
bipolar extracellular electrode located peripherally at the entry zone of the Mg/LgS.  In 
other instances, spontaneous EMG bursting was used to trigger an average from ventral 
roots just distal to their entry into the spinal cord.  Fig. 15 shows the general 
experimental setup and placement of intracellular and extracellular recording electrodes.   
 
Results 
 
 Intra-axonal recordings were obtained from 15 rats for analysis of axonal 
excitability and STA techniques.  Specifically, axonal excitability was studied in 4 control 
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and 7 OX (20 mg/kg) rats 24 hours post injection.  Five animals were used for sensory 
STA analysis at doses of 20 (2 rats), and 30 mg/kg (3 rats) at 24 to 96 hours post 
injection.  Motor STA analysis was done in 5 animals 24 hours after injection of 30 mg/kg 
OX. 
 
Validation of the Rodent Model 
 Acute neurotoxicity following OX infusion is characterized by symptoms of 
increased excitability in both sensory and motor systems.   For days following infusion of 
OX, patients describe both sensory and motor symptoms including: paresthesia, cold 
induced pain, and muscle cramps/fasciculation (Argyriou et al., 2008; Park et al., 2009b; 
Park et al., 2012a).  
 In our rodent model we observe sensory and motor dysfunction that persists for 
days following acute OX injection. Fig. 16 shows examples of sensory dysfunction 
following OX treatment.  In Fig. 16A spontaneous activity recorded from a muscle 
proprioceptor is shown, notice that firing continues despite shortening the muscle and 
removing all force.  Unprovoked firing in muscle proprioceptors is the proprioceptor 
correlate of paresthesia arising from cutaneous afferents in patients (Argyriou et al., 
2013a).  A correlate to cold induced symptoms is shown in Fig. 16B application of room 
temperature mineral oil to the triceps surae muscles resulted in burst of activity recorded 
intra-axonally from a Ia muscle spindle afferent.  Lastly, Fig. 16C shows spontaneous 
muscle activity similar to that observed in patients.  Similar to the motor signs of hyper-
excitability in patients, EMG showed repetitive (Fig. 16C, top trace) discharge with 
corresponding force production (Fig. 16C, bottom trace).  These electrophysiological 
measures fit well with patient described muscle fasciculation and cramping following OX 
infusion (Wilson et al., 2002; Lehky et al., 2004).  Therefore our model of acute OX 
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mimics the clinical presentation following OX infusion and suggest that findings in our 
rodent model will be highly relevant to patients. 
 
Additional Signs of Hyperexcitability 
 In addtion to the signs of hyperexcitability shown above, following OX treatment 
bursting activity was observed in numerous cells.   Similar to Fig. 16 above, Fig. 17A and 
B show bursting activity in muscle proprioceptors without stimulation.  In Fig. 17A the 
brief burst of repetitive firing persist during muscle shortening (removal of stimulus).  Fig. 
17B shows a robust increase in repetitive firing for roughly 20 sec before returning to a 
baseline despite no stimlutation (muscle stretch).  Bursts of activity can also be induced 
by muscle stretch.  Fig. 17C and D show bursts of activity elicited by either ramp-hold-
release or trianguar muscle stretch that persist after after the muscle stretch paradigm is 
removed.  In fact, during these burst of activity the axons become unresponsive to 
additional muscle stretch stimuli suggesting that their origin may be from the sensory 
terminal responsible for generating action potentials.   
 
Axonal Excitability 
 Hyperexcitability in muscle proprioceptors qualitatively mimics changes in 
excitability that result in the positive symptoms in patients.  The converging hypothesis 
from other studies is that acute OX alters axonal voltage-gated Na+ channels.  In order 
to assess changes in Na+ channels we tested the excitability of individual sesnory axons 
in vivo.  Table 2 compares axonal parameters in control and acute OX animals.   
Previous studies have demonstrated that OX shifts the activation and inactivation of 
voltage-gated Na+ channels to more negative potentials.  This shift would move 
threshold closer to resting membrane potentials and would reduce the overall amplitude 
of Na+ current.  Fig. 18 looks at the relationship between resting membrane potential and 
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the potential at which threshold is reached.  As membrane potential becomes more 
negative there is less build up of voltage-gated Na+ channel inactivation which results in 
a lower threshold (Novak et al. 2009).  Fig. 18B also shows that at a given membrane 
potential cells recorded from OX animals may have slightly lower thresholds than 
controls at a similar membrane potential.    If this were the case then the millivolts 
needed to reach threshold should be reduced in OX cells.  Fig. 18D shows the mean 
millivolts to threshold is slighlty reduced in OX, but this did not reach significance.  
Additionally, consistent with previous study we found that overall the amplitude of Na+ 
current was reduced in muscle proprioceptors following OX. Fig. 18A shows the effects 
of resting membrane potential on the maximal rate of rise (max DV/DT).  At similar 
membrane potentials, axons following acute OX showed lower max DV/DT suggesting 
that decreased number of voltage-gated Na+ channels were participating in the action 
potential.  Reduced max DV/DT also accounts for the reduction in action potential 
amplitude in table 2.  These changes may result from either decreased total numbers of 
channels or by a hyperpolarized shift in the inactivation when compared to control 
(Novak et al., 2009), which has been shown previously in acute OX (Adelsberger et al., 
2000; Grolleau et al., 2001; Benoit et al., 2006).   A comparison of means shows that 
while max DV/DT was reduced following OX, this effect did not reach significance.   
 
Localizing the Acute Effects of OX 
 Our assessment of indivdiual axon excitability following acute OX showed similar 
changes to those found in previous studies using in vitro or threshold tracking 
techniques.  While these changes are consistent with the previous literature, their 
magnitude seemed insufficient to account for the robust spontaneous activity in muscle 
proprioceptors.  If changes in axon excitability seem insuffiicient to cause spontaneous 
activity, then where does spontaneous activity originate? 
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 In order to answer this question we applied novel spike triggered averaging 
(STA) techniques to localize the origin of spontaneous sensory and motor activity.  If 
spontaneous sensory and motor activity arise from a single epicenter, then we should 
obtain a single average using STA.  Conversly, if spontaneous activity arises from 
numerous epicenters, as suggested by an increase in axonal exitability, then we should 
either obtain multiple averages with different latencies, or no clear average at all.  
   
Origin of Spontaneous Sensory Acivity 
 In 14 identified muscle proprioceptors from 7 rats spontaneous firing recorded 
intra-axonally was used to trigger an average from the peripheral recording electrode.  In 
8 of these 14, stretch evoked activity was used to trigger and average from the 
peripheral recording electrode.  The latencies of spontaneously, and stretch evoked, and 
electrically evoked (conduction delay) events were compared to determine the the origin 
of spontaneous activity following acute OX.   Fig. 19A and B shows two muscle 
proprioceptors in which STA on spontaneous and stretch evoked activity was obtained.  
In both cases spontaneously evoked STA latency occurs in the negative time window, 
meaning that the spontaneous action potentials crossed the peripheral recording 
electrode prior to being recorded intra-axonally in the dorsal roots.  Comparison of these 
latencies in each muscle proprioceptor with the latency of stretch evoked activity and the 
electrically evoked delay confirms that spontaneous activity arose from a peripheral 
origin, most likely the sensory nerve terminal.  Fig. 20 compares the mean latencies for 
spontaneously and stretch evoked STA, and the electrically evoked delay.  Electrically 
evoked delays were consistently the shortest, followed by spontaneous and then stretch 
evoked.  The slighlty longer latecny in stretch evoked may result from the relatively 
higher firing rates achieved in response to stretching the muscle as compared to 
spontaneous activity.  Also, stretch evoked delays may have been effected by the act of 
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stretching which moves the peripheral electrodes.  Regardless, in no case was the 
spontaneously evoked average faster than the electrically evoked delay for the same 
muscle proprioceptor and there was no signifcant differences between groups.  
 STA analysis suggests that spontaneous activity in muscle proprioceptors is 
arising from a peripheral epicenter, most likely the sensory nerve terminal.  In order to 
validate the STA method we applied the potent Na+ channel blocker bupivacaine locally 
at the entry zone of the triceps surae nerves.  If activity is arising from a peripheral 
epicenter, than blocking action potential initation peripherally should eliminate activity 
recorded from the dorsal roots. Fig. 21A and B shows two examples of the effects of 
locally applied bupivacaine on spontaneous activity in a muscle proprioceptors.  In both 
cases spontaneous firing ceases within approximately 30 seconds.  Conduction 
blockade was confirmed in the second case (Fig. 21C)  by failure to record action 
potentials in response to muscle stretch.  Results with bupivacaine confirm those 
obtained by STA, that spontaneous activity in muscle proprioceptors arises from a 
peripheral epicenter. 
 
Origin of Spontaneous Motor Activity 
 In order to determine the origin of spontaneous muscle activity, we used 
spontaneous EMG actitivty to trigger an average into ventral roots.  If spontaneous 
muscle activity results from abberrant motoneuron firing, then we should detect an 
average in the negative time window at a latency consistent with the delay of the 
compound muscle action potential.  In 5 animals, spontaneous EMG activity was used to 
obtain 8 averages from from ventral roots.  Fig. 22 shows two of these examples with 
their corresponding EMG and force traces.  In Fig. 22A an average from that contained 
two peaks with latencies of 3.2 and 3.5 ms.  Fig. 21B shows another example of an 
average containing two peaks with latencies of 2.9 and 3.3 ms respectively.  The two 
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different peaks in each of these examples likely arise from two different motor units with 
slightly different conduction velocities.   
 The total range of STA latencies observed was from 2.02 to 4.1 ms, which is 
consistent with the range of delays observed in the CMAP.  All of these averages were 
in the negative time window, meaning that the activity crossed the ventral root electrode 
prior to being recorded by the EMG electrodes.  Thus following acute OX spontaneous 
motor activity arises from a spinal cord epicenter, most likely the motoneuron.   
STA analysis demonstrates that spontaneous EMG activity results from motor unit firing 
evident by the averages obtained within ventral roots.  In order to validate the STA 
technique we paired down the ventral root until discrimitable activity was evident.  Fig. 
23A shows the resulting ventral root record with clear activity (arrowheads).  This activity 
then traveled to the periphery and activates the muscle, resutling in the EMG trace 
shown in Fig. 23B (3.8 ms delay).  Activation of this motor unit causes a small increase 
in muscle force showin in Fig. 23C.  
 If spontaneous muscle activity arises from motor unit firing, then blocking the 
acetylcholine receptor with pancuronium bromide should block neuromusclar 
transmission, eliminating spontaneous EMG activity.  Fig. 24 shows the effect of 
pancuronium bromide on spontaneous EMG activity.  In the first instance all 
spontaneous EMG activity ceases and there is no change in force (Fig. 24A).  Paralysis 
was confirmed by lack of force generation following supramaximal stimulation of the 
triceps surae nerves (Fig. 24B).  In a second animal pacuronium bromide was given and 
paralysis was confirmed by lack of force production following nerve stimulation, however 
spontaneous EMG activity was still present (Fig. 24C, top trace).  Note that despite the 
spontaneous EMG activity there is no increase in muscle force (Fig. 24C, bottom trace). 
This result was observed in a third animal following pancuronium bromide and suggests 
that in addtion to spontaneous motor unit activity originating in the spinal cord there is 
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spontaneous activity intrinsic to the muscle fiber(s), similar to myotonia (Lehky et al., 
2004; Novak et al., 2009)  
 
Disconnecting Sensory from Motor 
 The normal function of muscle proprioceptors is to provide feedback about 
muscle length and force to the central nervous system.  In the case of the Ia muscle 
spindle afferent this occurs through a monosynaptic connection with alpha motoneurons.  
Therefore, it is possible that spontaneous activity in muscle proprioceptors is contributing 
to the spontaneous muscle activity observed with EMG.  The converse is also true, that 
spontaneous motor activity could be driving the firing from muscle proprioceptors.  This 
could occur either from the changes in muscle length and force associated with motor 
unit firing, or in the case of muscle spindle direct input to intrafusal muscle fibers from 
gamma motoneurons.   
 The only way to be sure that spontaneous activity in muscle proprioceptors is a 
result of changes within the sensory cell it to eliminate the influence of alpha and gamma 
motoneurons on extrafusal and intrafusal muscle fibers.  This can be accomplished by 
either i.p. injection of pancuronium bromide, a potent inhibitor of nicotinic acetylcholine 
receptors, or by ventral root section.  Fig. 25 shows the effects of both of these 
procedures on spontaneous firing following OX.  Clearly, spontaneous activity persists 
after removal of motor influence by ventral root section (Fig. 25A) or pancuronium 
bromide injection (Fig. 25B).  In the same cell as Fig. 25B, STA analysis shows a latency 
consistent with a peripheral epicenter (Fig. 25C).  These results eliminate the possibility 
that spontaneous motor activity is driving the spontaneous sensory activity.   
 Conversely, in order to eliminate any effect of spontaneous sensory inputs to 
motoneurons we section the dorsal roots just prior to entering the spinal cord.  Fig. 26 
shows that even after eliminating sensory input, we still observed spontaneous EMG 
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activity and increases in muscle force. Just as before, that activity triggered an average 
in the ventral root  in the negative time window.  Thus, increased spontaneous activity 
from muscle propricoeptors is not necessary for spontaneous motor unit discharge, 
suggesting the OX is increasing the intrinsic excitability of motoneurons.   
 
Discussion 
 Following clinically relevant doses of OX, our rodent model showed signs of 
sensory and motor hyperexcitability which are qualitatively similar to the symptoms 
experienced by patients.  Our model showed spontaneous activity in muscle 
proprioceptors which correlates with paresthesia experienced by patients.  We also 
observed spontaneous increases in muscle force with corresponding repetitive EMG 
bursting.  Further investigation showed that this activity resulted from motor unit 
discharge and from myotonic like activity intrinsic to the muscle, both of which have been 
observed in patients (Wilson et al., 2002; Lehky et al., 2004).  Using novel in vivo intra-
axonal recording techniques to assess the previoulsy reported increase in axonal 
exctiability (Adelsberger et al., 2000; Grolleau et al., 2001; Benoit et al., 2006; Park et 
al., 2011b) we found changes that seemed unlikely to account for the large amount of 
spontaneous activity.  We then used STA techniques to determine the origin of 
spontaneous sensory and motor activity, and found that in both instances an epicenter 
consistent with the normal sites of action potential initiation and not in axons or dorsal 
root ganglion.  
 
Origin of Spontaneous Sensory and Motor Activity  
 STA analysis demonstrates that spontaneous sensory and motor activity 
following acute OX localizes to a single peripheral and central epicenter, respectively.  
This must be the case for two reasons: 1. If a single average was obtained, then there is 
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a single focal point generating activity, and 2. If the latency of these averages is 
consistent with the normal electrically evoked delay then they must have originated at or 
distal the recoding electode in the case of sensory activity and at or proxmimal to the 
recording electrode in the case of motor activity.  These two points eliminate the 
possibility of multiple epicenters along the length of the motor and sensory neuron, 
including the sensory neuron cell body in the dorsal root ganglion.   
 The origins of spontaneous sensory and motor activity were validated by further 
experimental manipulation.  Appilcation of bupivacaine to the nerve entry zone caused 
conduction block and stopped spontaneous sensory acticity.  This clearly demonstrated 
the peripheral origin of spotaneous sensory activity.  Spontaneous motor activity was 
confirmed by fine dissection of ventral roots which allowed for single motor units to be 
discriminated.  This activity resulted in EMG activity with normal delay and force 
production. Spontaneous motor unit activity was also confirmed by blocking 
acetylcholine receptors with pancuronium bromide.  Pancuronium bromide stopped 
motor unit EMG bursting and revealed spontaneous EMG activity intrinsic to the muscle.  
This activity likely results from the firing of random muscle fibers similar to myotonia 
congentia (Novak et al., 2015).  This finding is not surprising, as acute OX patients show 
signs of myotonia like symptoms, such as percussion myotonia and EMG studies have 
shown signs of myotonia (Wilson et al., 2002; Lehky et al., 2004).  This myotonia like 
activity was present in 2 out of 3 rats tested, however unlike the motor unit activity it 
produced no detectable changes in force.  This suggests that while there is likley an 
increase in the intrinsic excitability of muscle fibers, the spontaneous firing in motor units 
may have a larger role in the symptoms experienced by patients.  
 It is clear that both spontaneous sensory and motor activity origniate from sites of 
normal action potential initiation.  With respect to the motor side this is both the 
motoneuron and individual muscle fibers.  This demonstrates that in addition to a 
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peripheral effect, OX has a significant effect within the central nervous system.  
Localization of spontaneous activity to these sites provides insight into the underlying 
mechanism(s).   
 
Mechanism of Spontaneous Activity 
 The ability to generate trains of repetitive action potentials requires voltage-gated 
Na+ channels.  Votlage-gated Na+ channels conduct multiple types of Na current.  For 
instance, the transient Na+ current is responsible for the generation of action potentials, 
and persistent inward Na currents (NaPICs) are essetial for generationg trains of action 
potentials (Crill, 1996; Lee and Heckman, 1998, 2001; Harvey et al., 2006a).  Transient 
Na currents are necessarily present at action potential intiation sites, the distribution of 
NaPIC is less obvious.  However, given its essential role in repetitive firing, it or other 
mechansism supporting reptititve firing must be present at every site that where trains of 
action potentials are intitiated (Lee and Heckman, 2001).  The role of voltage-gated Na+ 
channel dysfunction following acute OX has been studied in numerous species and 
preparations, including human axons by threshold tracking.  The prevailing conclusion 
from these studies is that  OX effects voltage-gated Na channels leading to an increase 
in axonal excitability (Adelsberger et al., 2000; Grolleau et al., 2001; Benoit et al., 2006; 
Krishnan et al., 2006; Park et al., 2011b). 
 In the motoneuron, NaPIC has been shown to be essential for the intiation and 
maintenance of repetitive firing (Lee and Heckman, 1998, 2001; Harvey et al., 2006a).  
Using pharmacologic blockade, NaPIC has also been show to be essential for muscle 
proprioceptor encoding (Vincent et al., 2015).  Study of Na+ currents in muscle have 
identified a NaPIC that is present in individual muscle fibers (Gage et al., 1989).  
Additionally, channels like NaV 1.6, which have been shown to carry a NaPIC (Rush et 
al., 2007), in addition to a transient Na current, localize to the motoneuron axon initial 
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segement (Kole and Stuart, 2012),  sensory nerve terminal of muscle proprioceptors, 
and cutaneous receptors (Lesniak et al., 2014; Carrasco et al., 2017). The majority of 
stuides of acute OX neutoxicity have identified changes in the transient Na+ current.  
Specifically, this is thought to occur by a shift in the activation and inactivation of the 
voltage-gated Na+ current, which narrows the difference between resting membrane 
potential and action potential threshold (Adelsberger et al., 2000; Benoit et al., 2006).  In 
a more recent study acute OX has been shown to increase NaPIC in sensory neurons 
resulting in bursting (Sittl et al., 2012).    
 Insight into the relative contribution of transient Na+ current versus NaPIC to the 
hyperexcitability following acute OX comes from the types of spontaneous activity.  Both 
sensory and motor spontaneous activity consists of bursts of repetitive firing.  Fig. 
17C&D shows bursts of activity set off by muscle stretch, suggesting that the 
depolarization resulting from muscle stretch activated a current leading to a burst of 
repetitive firing.  Similarly, Fig. 16C shows a burst of repetitive EMG activity.  As 
discussed above, repetitive firing relies on NaPIC, suggesting that our findings may 
result from changes in NaPIC.   
 Further support for a change in NaPIC comes from our assessment of axonal 
excitability.  While we observed changes similar to previous studies in transient Na+ 
current present in axons, the magnitude of these changes seem unlikely to be the main 
contributor to the large amount of spontaneous activity in our model.  Additionally, if 
changes in transient Na+ current were the sole mechanism for spontaneous activity, then 
we might have expected our STA results to be different.  Transient Na+ current is 
present at every node of ranvier along the sensory and motor axon.  If changes in this 
current would result in multiple epicenters that would either give no clear average with 
STA analysis, or the localization of the epicenter would be at different points along the 
axon.  Our results with STA consistently localize to a single peripheral or central 
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epicenter.  Therefore, while changes in transient Na+ current cannot be ruled out as a 
contributor to spontaneous activity, our results suggest that changes in NaPIC are the 
major contributor.  Said in another way, spontaneous activity is present without 
significant changes in the transient Na+ current. 
 Based on previous studies and our results it is likely that acute OX causes an 
increase in a NaPIC present at action potential initiation sites, where it increases 
excitability resulting in spontaneous sensory and motor activity.  With respect to 
spontaneous motor unit discharge this increase likely occurs at the axon intitial segment.  
Whereas dendrites, which also have NaPIC (Prather et al., 2001; Heckman et al., 2003; 
Heckmann et al., 2005), may contribute to spontaneous activity initiated by synaptic 
drive, our results demonstrate that dendritic NaPIC activated by synaptic input is not 
necessary given that motor unit bursting persists after removing a large amount of 
synaptic input by dorsal root section.  
 Spontaneous, myotonia like activity in muscle fibers likely arises from an 
increase in the NaPIC normally found in skeletal muscle (Gage et al., 1989).  Given that 
muscle spindles are comprised of a sensory nerve terminal that innervates intrafusal 
muscle fibers it is possible that some sensory activity could arise from spontaneous 
discharge and contraction of the intrafusal fibers they innervate.  While this could 
contribute, the majority of activity likely arises from increased NaPIC that is present and 
essential for normal encoding in the sensory nerve terminal. 
 
Conclusion 
 OX infusion results in debilitating sensory and motor symptoms.  We have 
demonstrated that our rodent muscle proprioceptor model shows qualitatively similar 
types of spontaneous activity in sensory and motor systems.  Following acute OX, we 
observed spontanteous activity in muscle proprioceptors, EMG bursting, and 
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temperature dependent increases in activity.  Previous studies have suggested that 
these symptoms arise from changes in votlage-gated Na+ channels present in sensory 
and motor axons (Adelsberger et al., 2000; Grolleau et al., 2001; Wilson et al., 2002; 
Benoit et al., 2006).  We tested this hypothesis by assessing the excitabilty of individual 
axons using in vivo intra-axonal recordings.  The changes, while similar to previous 
studies were very small and seemed unlikely to account for the amount of spontaneous 
activity we observed.  Further analysis using novel STA techniques localized the origin 
of spotaneous sensory and motor activity to the normal site of action potential initiation, 
ie sensory nerve terminal, motoneuron, and muscle fiber.  This suggests that OX targets 
specific mechanisms at these locations.  Given that spontaneous activity consisted of 
bursts of repetitive firing our results suggest that acute OX may increase NaPIC present 
at action potential initiation sites.  This finding fits well with results from aim 1, which 
suggests that chronic OX effects NaPIC present at the sensory nerve terminal.  Overall 
our report provides insight into the effects of acute OX and suggest that changes in 
NaPIC may link acute and chronic changes following OX.   
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Fig. 15 Experimental Setup.  Evoked and spontaneous action potentials were recorded 
intra-axonally within dorsal roots.  These action potentials were used to trigger an 
average from the peripheral bipolar electrode.  The latencies of electrically, stretch 
evoked and spontaneous averages will be compared. Spontaneous EMG spikes 
recorded from the triceps surae were used to trigger averages from ventral roots.  The 
latency of these averages were compared with the compound muscle action potential 
latency elicited by ventral root stimulation. 
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Fig. 16.  Validation of acute OX neurotoxicity in our rodent model.  Representative 
traces, A,B gray lines are action potentials, black dots show instaneous firing rates.  (A) 
Spontaneous activity from a muscle proprioceptor following OX injection.  Note that the 
muscle proprioceptor keeps firing despite decreasing muscle length and force.  (B)  
Burst of activity from a muscle proprioceptor following application of room temperature 
mineral oil to the body of the triceps surae muscle.  Force trace below shows the 
moment when oil was applied.  (C)  EMG trace (top) showing repetitive motor unit 
discharge and corresponding force production (bottom trace).  
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Fig. 17.  Representative examples of bursting activity following OX.  Representative 
traces of spontaneous activity (A-D), gray lines are action potentials, black dots show 
instaneous firing rates.   (A)  Brief bursts of activity from a muscle proprioceptor that 
persist despite muscle shortening.  (B)  Extended period of unprovoked repetitive firing.  
(C,D)  Bursting activity in muscle proprioceptors can be initated by muscle stretch (C) 
ramp hold release, 3 mm, 4 mm/s, 1 sec hold phase, (D) triangular stretch, 3 mm 4 
mm/s).  
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Fig. 18.  Measures of axonal excitability in control and OX treated rats.  (A) Plot of 
max DV/DT (rate of rise of the action potential) versus membrane potential.  Compared 
to control, OX axons have lower max DV/DT suggesting lower less Na+ channels are 
participating in action potential formation.  (B)  Changes in threshold are largely 
attributed to changes in membrane potential.  There is some tendency for OX axons to 
fall below the line, suggesting that they rest closer to threshold.  (C)  Mean ± SE 
comparison of max DV/DT in control and OX axons. (D)  Mean ± SE comparison of 
millivolts to threshold in control and OX axons.   
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Table 2.  Assessment of excitability parameters in axons.  In control (4 rats) and 24 
hours after acute oxaliplatin (20 mg/kg, 7 rats) axonal parameters were recorded intra-
axonally in terminal experiments. n, number of afferents pooled within groups.  Nested 
ANOVA and Tukey’s post hoc tests were used to test for the significance of group 
differences. * P < 0.05 
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Fig. 19.  Two representative examples of spike triggerd averaging in muscle 
proprioceptors showing spontaneous activity.  Dashed line denotes time zero (time 
of action potential recorded intra-axonally).  (A,B)  Averages obtained using STA from 
stretch (top) and spontaneous (bottom) activity in muscle propricoeptors following OX. 
(C)  Mean ± 95% confidence interval comparison of latencies from spontaneous, stretch 
evoked averages with the electrically evoked delay.   
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Fig. 20.  Comparison of electrically evoked delay with STA latencies from 
spontaneous and stretch evoked activity. Mean ± 95% confidence interval  
comparison of latencies from spontaneous, stretch evoked averages with the electrically 
evoked delay.   
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Fig. 21.  Effects of bupivacaine applied locally to the nerve entry zone.  A-C gray 
lines are action potentials, black dots show instaneous firing rates.    (A,B)  Arrowheads 
show when bupivacaine was locally applied.  Within 30 sec spontaneous activity ceased.  
(C)  Conduction block was confirmed in the cell shown in B, by an absence of stretch 
responses. 
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Fig. 22.  STA analysis of spontaneous EMG activity.  Dashed lines denote time zero 
(time at which the EMG spike occurred).  (A,B) Two examples of averages (bottom 
trace) in ventral roots obtained from spontaneous EMG activity (top trace) with 
corresponding changes in force (middle trace). 
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Fig. 23.  Spontaneous motor unit firing results in EMG activity and corresponding 
increase in muscle force.  (A)  Ventral root record from bipolary recording elcetrode 
shows two bursts of activity (arrowheads).  (B)  EMG record with activity arising 3.8 ms 
after ventral root activity.  (C)  Muscle force trace showing increases in muscle for 
following EMG activity.  
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Fig. 24.  Spontanous muscle activity results from motor unit and muscle fiber 
firing.  (A)  EMG record (top trace) showing spontaneous activity with corresponding 
changes in force (bottom trace).  Following injection of pancuronium bromide EMG 
activity disappears.   (B)  Following pancuronium bromide injection supramaximal 
simtulation of the periphaeral nerve (arrowheads) results in no increase in muscel force.  
(C)  Following paralyzation with pancuronium bromide, EMG record (top trace) showing 
spontaneous muscle fiber activity with no change in muscle force (bottom trace). 
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Fig. 25.  Elimination of motor influence had no effect on spontaneous activity in 
muscle proprioceptors.  (A)  Ventral root section prior to recording did not prevent 
spontaneous firing.  (B)  Similarly, paralyzation with pancuronium bromide had no effect 
on spontaeous activity.  (C)  In the same cell as (C), pancuronium injection had no effect 
on the STA latency.  
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Fig. 26.  Elimination of sensory input had no effect on spontaneous muscle 
activity.  Cutting dorsal roots did not eliminate spontaneous EMG bursting (top trace) or 
force production (middle trace).  STA analysis of EMG record produced an average 
(bottom trace) from ventral roots. 
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Chapter VII 
 
Conclusions 
 Adjuvant treatment with OX chemotherapy results in neutotoxic side effects 
which greatly impact the lives of patients during and long after cessation of treatment.  
Given the realtively high diease free survival rate following colorectal cancer, these 
neurotoxic sides effects force patients to endure a lower quality of life.  Aims in this 
disseration specifically target acute and chronic OX neurotoxicity.  We have identified 
novel mechanisms of proprioceptive deficits following chronic OX that may account for 
the disparity in the severity of patient reported symptoms and those predicted by 
physicians.  Our study of acute OX has led to novel conclusions about where activity that 
underlies symptoms originates and how this might shed light on the underlying 
mechanisms.     
 
Chronic OX Neurotoxicity 
 Our animal model of chronic OX replicates the clinical scenario in which patients 
without neuropathy develop debilitating proprioceptive deficits.  Through our use of in 
vivo electrophysiology we identified a deficit in encoding which correlated with the 
severity of behavioral impairement.  Through pharmacologic investigation we discovered 
that OX most likley disrupted a NaPIC necessary for normal propricoeptor function.  This 
finding is novel and provides for the first time an explanation of deficits without 
neuropathy.  Importantly this finding may also help explain the disparity in severity of 
symptoms described above and provides a potential therapeutic target (Fig. 27).
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Targeting NaPIC was capable of restoring encoding, and because of the correlation 
between the encoding deficit and behavioral impairment, suggests that this treatment 
may alleviate proprioceptive deficits following chronic OX.   
 
Acute Neurotoxicity 
 Our acute OX model shows qualitatively similar changes to those that underlie 
positive symptoms in patients.  It is evident from our results and previous studies that 
these symptoms arise from an increase in excitability.  Unlike previous studies, 
significant changes in axonal excitability as assesed by measurements of transient Na+ 
current were not present.  Further investigation with STA techniques localizes these 
changes to the normal action potential initiation sites.  This and the types of activity 
present suggested that acute OX may be altering excitability, potentially by increasing 
NaPIC.    
 
Connecting Acute and Chronic OX Neurotoxicity 
 A major goal of OX research has been to identify a causal link between acute 
and chronic forms of OX neurotoxicity.  Previous studies have identified that the 
development and severity of acute symptoms correlates with the development and 
severity of chronic symptoms (Krishnan et al., 2006; Park et al., 2009a).  Specific 
polymoprhisms in voltage-gated Na+ channels have been shown to correlate with the 
severity of acute and chronic OX neurotoxicity (Argyriou et al., 2013b).  The studies have 
provided support for a link between acute and chronic OX neurotoxicity, but have failed 
to identify a causal link or to develop a perventative treatment.   
 This results presented above provide for the first time, insight into a potential 
unified mechanism for acute and chronic OX neurotoxicity.  Results in this dissertation 
demonstrate two main points: 1.  Acute and chronic OX neurotoxicity localize to the 
 
 
129 
sensory nerve terminal, and 2. Acute and chronic OX neurotoxicty may have opposite 
effects on NaPIC.  Acute OX likely increases NaPIC in muscle proprioceptors leading to 
spontaneous activity for days following injection.  After several injections of OX and after 
treatment cessartion, NaPIC is decreased in muscle proprioceptors leading to impaired 
encoding.   
 These results suggest that NaPIC activity is being homeostatically controlled.  
Regulation of NaPIC based on cellular excitability has been shown in other clinical 
scenarios.  For instance, following chronic spinal cord injury, in order to compensate for 
loss of descending excitatory inputs and lower motoneuron excitability, there is a 
clinically significant increase in PICs within motoneurons leading to spasticity (Gorassini 
et al., 2004; Li et al., 2004; Murray et al., 2010; Murray et al., 2011).   
 We propose that during OX treament the increased excitability and positive 
symptoms experienced by patients result from increased NaPIC in sensory and 
motoneurons.  After mulitple infusions of OX, hyperexcitability stresses sensory and 
motoneurons.  In an attempt to compensate the neurons reduce their excitability by 
decreasing the amount of NaPIC, contributing to the negative symptoms experienced by 
patients.  Although not studied here, a failure to reduce exctiability may result in 
excitotoxicity and cell death consistent with the other proposed cause of chronic OX 
neurotoxicity (Carozzi et al., 2015).  Acute hyperexcitability is a potential therapeutic 
target aimed at alleviating the positive symptoms experienced by patients and 
preventing the development of chronic persistent negative symptoms (Fig. 27). 
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Fig. 27. Clinical progression of OX neurotoxicity.  In the majority of patients acute 
neurotoxicity occurs with every OX infusion.  Accumulating doses of OX result in chronic 
neurotoxicity, which persists after treatment cessation.  Aim 2 established a potential 
therapeutic target to alleviate chronic neurotoxic symptoms.  If acute and chronic 
neurotoxicity are casually linked, then blocking acute changes will prevent the 
development of chronic symptoms. 
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Chapter VIII  
 
References 
 
 
 
Abelew TA, Miller MD, Cope TC, Nichols TR (2000) Local loss of proprioception results 
in disruption of interjoint coordination during locomotion in the cat. Journal of 
neurophysiology 84:2709-2714. 
Adelsberger H, Quasthoff S, Grosskreutz J, Lepier A, Eckel F, Lersch C (2000) The 
chemotherapeutic oxaliplatin alters voltage-gated Na(+) channel kinetics on rat 
sensory neurons. European journal of pharmacology 406:25-32. 
Akay T, Tourtellotte WG, Arber S, Jessell TM (2014) Degradation of mouse locomotor 
pattern in the absence of proprioceptive sensory feedback. Proceedings of the 
National Academy of Sciences of the United States of America 111:16877-
16882. 
Alzheimer C, Schwindt PC, Crill WE (1993) Modal gating of Na+ channels as a 
mechanism of persistent Na+ current in pyramidal neurons from rat and cat 
sensorimotor cortex. J Neurosci 13:660-673. 
Anderson RJ, Raines A (1974) Suppression by diphenylhydantoin of afferent discharges 
arising in muscle spindles of the triceps surae of the cat. The Journal of 
pharmacology and experimental therapeutics 191:290-299. 
Andre T, Boni C, Navarro M, Tabernero J, Hickish T, Topham C, Bonetti A, Clingan P, 
Bridgewater J, Rivera F, de Gramont A (2009) Improved overall survival with 
oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III 
colon cancer in the MOSAIC trial. Journal of clinical oncology : official journal of 
the American Society of Clinical Oncology 27:3109-3116. 
Aniss AM, Diener HC, Hore J, Gandevia SC, Burke D (1990) Behavior of human muscle 
receptors when reliant on proprioceptive feedback during standing. Journal of 
neurophysiology 64:661-670.
 
 
133 
Antonow-Schlorke I, Ehrhardt J, Knieling M (2013) Modification of the ladder rung 
walking task-new options for analysis of skilled movements. Stroke research and 
treatment 2013:418627. 
Argyriou AA, Kyritsis AP, Makatsoris T, Kalofonos HP (2014) Chemotherapy-induced 
peripheral neuropathy in adults: a comprehensive update of the literature. Cancer 
management and research 6:135-147. 
Argyriou AA, Polychronopoulos P, Iconomou G, Chroni E, Kalofonos HP (2008) A review 
on oxaliplatin-induced peripheral nerve damage. Cancer treatment reviews 
34:368-377. 
Argyriou AA, Cavaletti G, Briani C, Velasco R, Bruna J, Campagnolo M, Alberti P, 
Bergamo F, Cortinovis D, Cazzaniga M, Santos C, Papadimitriou K, Kalofonos 
HP (2013a) Clinical pattern and associations of oxaliplatin acute neurotoxicity: a 
prospective study in 170 patients with colorectal cancer. Cancer 119:438-444. 
Argyriou AA, Cavaletti G, Antonacopoulou A, Genazzani AA, Briani C, Bruna J, 
Terrazzino S, Velasco R, Alberti P, Campagnolo M, Lonardi S, Cortinovis D, 
Cazzaniga M, Santos C, Psaromyalou A, Angelopoulou A, Kalofonos HP (2013b) 
Voltage-gated sodium channel polymorphisms play a pivotal role in the 
development of oxaliplatin-induced peripheral neurotoxicity: results from a 
prospective multicenter study. Cancer 119:3570-3577. 
Avan A, Postma TJ, Ceresa C, Avan A, Cavaletti G, Giovannetti E, Peters GJ (2015) 
Platinum-induced neurotoxicity and preventive strategies: past, present, and 
future. The oncologist 20:411-432. 
Banks RW (2006) An allometric analysis of the number of muscle spindles in 
mammalian skeletal muscles. Journal of anatomy 208:753-768. 
Banks RW, Barker D, Stacey MJ (1982) Form and distribution of sensory terminals in cat 
hindlimb muscle spindles. Philosophical transactions of the Royal Society of 
London Series B, Biological sciences 299:329-364. 
Banks RW, Hulliger M, Scheepstra KA, Otten E (1997) Pacemaker activity in a sensory 
ending with multiple encoding sites: the cat muscle spindle primary ending. The 
Journal of physiology 498 ( Pt 1):177-199. 
Banks RW, Hulliger M, Saed HH, Stacey MJ (2009) A comparative analysis of the 
encapsulated end-organs of mammalian skeletal muscles and of their sensory 
nerve endings. Journal of anatomy 214:859-887. 
 
 
134 
Barker D (1948) The innervation of the muscle-spindle. The Quarterly journal of 
microscopical science 89:143-186. 
Beijers AJ, Mols F, Vreugdenhil G (2014) A systematic review on chronic oxaliplatin-
induced peripheral neuropathy and the relation with oxaliplatin administration. 
Supportive care in cancer : official journal of the Multinational Association of 
Supportive Care in Cancer 22:1999-2007. 
Bellingham MC (2011) A review of the neural mechanisms of action and clinical 
efficiency of riluzole in treating amyotrophic lateral sclerosis: what have we 
learned in the last decade? CNS neuroscience & therapeutics 17:4-31. 
Bellingham MC (2013) Pre- and postsynaptic mechanisms underlying inhibition of 
hypoglossal motor neuron excitability by riluzole. Journal of neurophysiology 
110:1047-1061. 
Bennett BK, Park SB, Lin CS, Friedlander ML, Kiernan MC, Goldstein D (2012) Impact 
of oxaliplatin-induced neuropathy: a patient perspective. Supportive care in 
cancer : official journal of the Multinational Association of Supportive Care in 
Cancer 20:2959-2967. 
Benoit E, Escande D (1991) Riluzole specifically blocks inactivated Na channels in 
myelinated nerve fibre. Pflugers Archiv : European journal of physiology 419:603-
609. 
Benoit E, Brienza S, Dubois JM (2006) Oxaliplatin, an anticancer agent that affects both 
Na+ and K+ channels in frog peripheral myelinated axons. General physiology 
and biophysics 25:263-276. 
Bewick GS, Banks RW (2015) Mechanotransduction in the muscle spindle. Pflugers 
Archiv : European journal of physiology 467:175-190. 
Bewick GS, Reid B, Richardson C, Banks RW (2005) Autogenic modulation of 
mechanoreceptor excitability by glutamate release from synaptic-like vesicles: 
evidence from the rat muscle spindle primary sensory ending. The Journal of 
physiology 562:381-394. 
Black JA, Dib-Hajj S, McNabola K, Jeste S, Rizzo MA, Kocsis JD, Waxman SG (1996) 
Spinal sensory neurons express multiple sodium channel alpha-subunit mRNAs. 
Brain research Molecular brain research 43:117-131. 
 
 
135 
Boyd IA (1968) The structure and innervation of mammalian muscle spindles. 
Electroencephalography and clinical neurophysiology 25:406. 
Boyd IA, Ward J (1975) Motor control of nuclear bag and nuclear chain intrafusal fibres 
in isolated living muscle spindles from the cat. The Journal of physiology 244:83-
112. 
Boyd IA, Gladden MH, McWilliam PN, Ward J (1977) Control of dynamic and static 
nuclear bag fibres and nuclear chain fibres by gamma and beta axons in isolated 
cat muscle spindels. The Journal of physiology 265:133-162. 
Briani C, Argyriou AA, Izquierdo C, Velasco R, Campagnolo M, Alberti P, Frigeni B, 
Cacciavillani M, Bergamo F, Cortinovis D, Cazzaniga M, Bruna J, Cavaletti G, 
Kalofonos HP (2014) Long-term course of oxaliplatin-induced polyneuropathy: a 
prospective 2-year follow-up study. Journal of the peripheral nervous system : 
JPNS 19:299-306. 
Bullinger KL, Nardelli P, Pinter MJ, Alvarez FJ, Cope TC (2011a) Permanent central 
synaptic disconnection of proprioceptors after nerve injury and regeneration. II. 
Loss of functional connectivity with motoneurons. Journal of neurophysiology 
106:2471-2485. 
Bullinger KL, Nardelli P, Wang Q, Rich MM, Cope TC (2011b) Oxaliplatin neurotoxicity of 
sensory transduction in rat proprioceptors. Journal of neurophysiology 106:704-
709. 
Burakgazi AZ, Messersmith W, Vaidya D, Hauer P, Hoke A, Polydefkis M (2011) 
Longitudinal assessment of oxaliplatin-induced neuropathy. Neurology 77:980-
986. 
Burke D, Hagbarth KE, Lofstedt L (1978) Muscle spindle activity in man during 
shortening and lengthening contractions. The Journal of physiology 277:131-142. 
Burke RE, Strick PL, Kanda K, Kim CC, Walmsley B (1977) Anatomy of medial 
gastrocnemius and soleus motor nuclei in cat spinal cord. Journal of 
neurophysiology 40:667-680. 
Carozzi VA, Canta A, Chiorazzi A (2015) Chemotherapy-induced peripheral neuropathy: 
What do we know about mechanisms? Neuroscience letters 596:90-107. 
 
 
136 
Carrasco DI, Vincent JA, Cope TC (2017) Distribution of TTX-sensitive voltage-gated 
sodium channels in primary sensory endings of mammalian muscle spindles. 
Journal of neurophysiology:jn 00889 02016. 
Cavaletti G (2014) Chemotherapy-induced peripheral neurotoxicity (CIPN): what we 
need and what we know. Journal of the Peripheral Nervous System 19:66-76. 
Cavaletti G, Tredici G, Petruccioli MG, Donde E, Tredici P, Marmiroli P, Minoia C, 
Ronchi A, Bayssas M, Etienne GG (2001) Effects of different schedules of 
oxaliplatin treatment on the peripheral nervous system of the rat. European 
journal of cancer 37:2457-2463. 
Chopek JW, MacDonell CW, Power KE, Gardiner K, Gardiner PF (2013) Removal of 
supraspinal input reveals a difference in the flexor and extensor monosynaptic 
reflex response to quipazine independent of motoneuron excitation. Journal of 
neurophysiology 109:2056-2063. 
Chung G, Saito M, Kawasaki Y, Kawano T, Yin D, Lee S, Kogo M, Takada M, Bae YC, 
Kim JS, Oh SB, Kang Y (2015) Generation of resonance-dependent oscillation 
by mGluR-I activation switches single spiking to bursting in mesencephalic 
trigeminal sensory neurons. The European journal of neuroscience 41:998-1012. 
Crill WE (1996) Persistent sodium current in mammalian central neurons. Annual review 
of physiology 58:349-362. 
Crowe A, Matthews PB (1964) The Effects of Stimulation of Static and Dynamic 
Fusimotor Fibres on the Response to Stretching of the Primary Endings of 
Muscle Spindles. The Journal of physiology 174:109-131. 
De-Doncker L, Picquet F, Petit J, Falempin M (2003) Characterization of spindle 
afferents in rat soleus muscle using ramp-and-hold and sinusoidal stretches. 
Journal of neurophysiology 89:442-449. 
Deuis JR, Lim YL, Rodrigues de Sousa S, Lewis RJ, Alewood PF, Cabot PJ, Vetter I 
(2014) Analgesic effects of clinically used compounds in novel mouse models of 
polyneuropathy induced by oxaliplatin and cisplatin. Neuro-oncology 16:1324-
1332. 
Dimitriou M, Edin BB (2010) Human muscle spindles act as forward sensory models. 
Current biology : CB 20:1763-1767. 
 
 
137 
Djupsjobacka M, Johansson H, Bergenheim M, Wenngren BI (1995) Influences on the 
gamma-muscle spindle system from muscle afferents stimulated by increased 
intramuscular concentrations of bradykinin and 5-HT. Neuroscience research 
22:325-333. 
Doble A (1996) The pharmacology and mechanism of action of riluzole. Neurology 
47:S233-241. 
Eccles JC, Eccles RM, Iggo A, Lundberg A (1960) Electrophysiological studies on 
gamma motoneurones. Acta physiologica Scandinavica 50:32-40. 
Edin BB, Vallbo AB (1990a) Dynamic response of human muscle spindle afferents to 
stretch. Journal of neurophysiology 63:1297-1306. 
Edin BB, Vallbo AB (1990b) Muscle afferent responses to isometric contractions and 
relaxations in humans. Journal of neurophysiology 63:1307-1313. 
Edin BB, Vallbo AB (1990c) Classification of human muscle stretch receptor afferents: a 
Bayesian approach. Journal of neurophysiology 63:1314-1322. 
Ellaway PH, Trott JR (1975) The mode of action of 5-hydroxytryptophan in facilitating a 
stretch reflex in the spinal cat. Experimental brain research 22:145-162. 
Ellaway PH, Taylor A, Durbaba R (2015) Muscle spindle and fusimotor activity in 
locomotion. Journal of anatomy 227:157-166. 
Enjin A, Leao KE, Mikulovic S, Le Merre P, Tourtellotte WG, Kullander K (2012) 
Sensorimotor function is modulated by the serotonin receptor 1d, a novel marker 
for gamma motor neurons. Molecular and cellular neurosciences 49:322-332. 
Eriksson PO, Butler-Browne GS, Thornell LE (1994) Immunohistochemical 
characterization of human masseter muscle spindles. Muscle & nerve 17:31-41. 
Fehrenbacher JC (2015) Chemotherapy-induced peripheral neuropathy. Progress in 
molecular biology and translational science 131:471-508. 
Franceschetti S, Taverna S, Sancini G, Panzica F, Lombardi R, Avanzini G (2000) 
Protein kinase C-dependent modulation of Na+ currents increases the excitability 
of rat neocortical pyramidal neurones. The Journal of physiology 528 Pt 2:291-
304. 
 
 
138 
Freireich EJ, Gehan EA, Rall DP, Schmidt LH, Skipper HE (1966) Quantitative 
comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, 
and man. Cancer chemotherapy reports Part 1 50:219-244. 
Gage PW, Lamb GD, Wakefield BT (1989) Transient and persistent sodium currents in 
normal and denervated mammalian skeletal muscle. The Journal of physiology 
418:427-439. 
Gorassini MA, Knash ME, Harvey PJ, Bennett DJ, Yang JF (2004) Role of motoneurons 
in the generation of muscle spasms after spinal cord injury. Brain : a journal of 
neurology 127:2247-2258. 
Grolleau F, Gamelin L, Boisdron-Celle M, Lapied B, Pelhate M, Gamelin E (2001) A 
possible explanation for a neurotoxic effect of the anticancer agent oxaliplatin on 
neuronal voltage-gated sodium channels. Journal of neurophysiology 85:2293-
2297. 
Grothey A (2003) Oxaliplatin-safety profile: neurotoxicity. Seminars in oncology 30:5-13. 
Grunnet M, Jespersen T, Angelo K, Frokjaer-Jensen C, Klaerke DA, Olesen SP, Jensen 
BS (2001) Pharmacological modulation of SK3 channels. Neuropharmacology 
40:879-887. 
Haftel VK, Bichler EK, Nichols TR, Pinter MJ, Cope TC (2004) Movement reduces the 
dynamic response of muscle spindle afferents and motoneuron synaptic 
potentials in rat. Journal of neurophysiology 91:2164-2171. 
Harvey PJ, Li Y, Li X, Bennett DJ (2006a) Persistent sodium currents and repetitive firing 
in motoneurons of the sacrocaudal spinal cord of adult rats. Journal of 
neurophysiology 96:1141-1157. 
Harvey PJ, Li X, Li Y, Bennett DJ (2006b) 5-HT2 receptor activation facilitates a 
persistent sodium current and repetitive firing in spinal motoneurons of rats with 
and without chronic spinal cord injury. Journal of neurophysiology 96:1158-1170. 
Heckman CJ, Lee RH, Brownstone RM (2003) Hyperexcitable dendrites in motoneurons 
and their neuromodulatory control during motor behavior. Trends in 
neurosciences 26:688-695. 
Heckmann CJ, Gorassini MA, Bennett DJ (2005) Persistent inward currents in 
motoneuron dendrites: implications for motor output. Muscle & nerve 31:135-156. 
 
 
139 
Houk JC, Singer JJ, Henneman E (1971) Adequate stimulus for tendon organs with 
observations on mechanics of ankle joint. Journal of neurophysiology 34:1051-
1065. 
Huang CS, Song JH, Nagata K, Yeh JZ, Narahashi T (1997) Effects of the 
neuroprotective agent riluzole on the high voltage-activated calcium channels of 
rat dorsal root ganglion neurons. The Journal of pharmacology and experimental 
therapeutics 282:1280-1290. 
Hunt CC, Wilkinson RS, Fukami Y (1978) Ionic basis of the receptor potential in primary 
endings of mammalian muscle spindles. The Journal of general physiology 
71:683-698. 
Hunt CC, McIntyre (1974) Muscle Recpetors. New York: Springer-Verlag  
Iggo A, Muir AR (1969) The structure and function of a slowly adapting touch corpuscle 
in hairy skin. The Journal of physiology 200:763-796. 
Inui N, Walsh LD, Taylor JL, Gandevia SC (2011) Dynamic changes in the perceived 
posture of the hand during ischaemic anaesthesia of the arm. The Journal of 
physiology 589:5775-5784. 
Ivanenko YP, Dominici N, Daprati E, Nico D, Cappellini G, Lacquaniti F (2011) 
Locomotor body scheme. Human movement science 30:341-351. 
Jami L (1992) Golgi tendon organs in mammalian skeletal muscle: functional properties 
and central actions. Physiological reviews 72:623-666. 
Jamieson SM, Liu J, Connor B, McKeage MJ (2005) Oxaliplatin causes selective atrophy 
of a subpopulation of dorsal root ganglion neurons without inducing cell loss. 
Cancer chemotherapy and pharmacology 56:391-399. 
Jankowska E, Gladden MH, Czarkowska-Bauch J (1998) Modulation of responses of 
feline gamma-motoneurones by noradrenaline, tizanidine and clonidine. The 
Journal of physiology 512 ( Pt 2):521-531. 
Kakuda N, Vallbo AB, Wessberg J (1996) Fusimotor and skeletomotor activities are 
increased with precision finger movement in man. The Journal of physiology 492 
( Pt 3):921-929. 
 
 
140 
Kiernan MC (2007) The pain with platinum: oxaliplatin and neuropathy. European journal 
of cancer 43:2631-2633. 
Kneis S, Wehrle A, Freyler K, Lehmann K, Rudolphi B, Hildenbrand B, Bartsch HH, 
Bertz H, Gollhofer A, Ritzmann R (2015) Balance impairments and 
neuromuscular changes in breast cancer patients with chemotherapy-induced 
peripheral neuropathy. Clinical neurophysiology : official journal of the 
International Federation of Clinical Neurophysiology. 
Kole MH, Stuart GJ (2012) Signal processing in the axon initial segment. Neuron 
73:235-247. 
Krinke G, Naylor DC, Skorpil V (1985) Pyridoxine megavitaminosis: an analysis of the 
early changes induced with massive doses of vitamin B6 in rat primary sensory 
neurons. Journal of neuropathology and experimental neurology 44:117-129. 
Krishnan AV, Goldstein D, Friedlander M, Kiernan MC (2005) Oxaliplatin-induced 
neurotoxicity and the development of neuropathy. Muscle & nerve 32:51-60. 
Krishnan AV, Goldstein D, Friedlander M, Kiernan MC (2006) Oxaliplatin and axonal 
Na+ channel function in vivo. Clinical cancer research : an official journal of the 
American Association for Cancer Research 12:4481-4484. 
Lagerback PA (1985) An ultrastructural study of cat lumbosacral gamma-motoneurons 
after retrograde labelling with horseradish peroxidase. The Journal of 
comparative neurology 240:256-264. 
Lamanauskas N, Nistri A (2008) Riluzole blocks persistent Na+ and Ca2+ currents and 
modulates release of glutamate via presynaptic NMDA receptors on neonatal rat 
hypoglossal motoneurons in vitro. The European journal of neuroscience 
27:2501-2514. 
Lampl I, Schwindt P, Crill W (1998) Reduction of cortical pyramidal neuron excitability by 
the action of phenytoin on persistent Na+ current. The Journal of pharmacology 
and experimental therapeutics 284:228-237. 
Lee RH, Heckman CJ (1998) Bistability in spinal motoneurons in vivo: systematic 
variations in persistent inward currents. Journal of neurophysiology 80:583-593. 
Lee RH, Heckman CJ (2001) Essential role of a fast persistent inward current in action 
potential initiation and control of rhythmic firing. Journal of neurophysiology 
85:472-475. 
 
 
141 
Lehky TJ, Leonard GD, Wilson RH, Grem JL, Floeter MK (2004) Oxaliplatin-induced 
neurotoxicity: acute hyperexcitability and chronic neuropathy. Muscle & nerve 
29:387-392. 
Lesniak DR, Marshall KL, Wellnitz SA, Jenkins BA, Baba Y, Rasband MN, Gerling GJ, 
Lumpkin EA (2014) Computation identifies structural features that govern 
neuronal firing properties in slowly adapting touch receptors. eLife 3:e01488. 
Lewin GR, McMahon SB (1991) Physiological properties of primary sensory neurons 
appropriately and inappropriately innervating skin in the adult rat. Journal of 
neurophysiology 66:1205-1217. 
Li Y, Gorassini MA, Bennett DJ (2004) Role of persistent sodium and calcium currents in 
motoneuron firing and spasticity in chronic spinal rats. Journal of 
neurophysiology 91:767-783. 
Liu JX, Thornell LE, Pedrosa-Domellof F (2003) Muscle spindles in the deep muscles of 
the human neck: a morphological and immunocytochemical study. The journal of 
histochemistry and cytochemistry : official journal of the Histochemistry Society 
51:175-186. 
Macefield VG (2005) Physiological characteristics of low-threshold mechanoreceptors in 
joints, muscle and skin in human subjects. Clinical and experimental 
pharmacology & physiology 32:135-144. 
Matthews PB (1962) The differentiation of two types of fusimotor fibre by their effects on 
the dynamic response of muscle spindle primary endings. Quarterly journal of 
experimental physiology and cognate medical sciences 47:324-333. 
Matthews PB (1963) The Response of De-Efferented Muscle Spindle Receptors to 
Stretching at Different Velocities. The Journal of physiology 168:660-678. 
Matthews PBC (1972) In: Mammalian Muscle Receptors and Their Central Actions, pp 
1-59. Baltimore: The Williams and Wilkins Company. 
Metz GA, Whishaw IQ (2002) Cortical and subcortical lesions impair skilled walking in 
the ladder rung walking test: a new task to evaluate fore- and hindlimb stepping, 
placing, and co-ordination. Journal of neuroscience methods 115:169-179. 
Metz GA, Whishaw IQ (2009) The ladder rung walking task: a scoring system and its 
practical application. Journal of visualized experiments : JoVE. 
 
 
142 
Meyer PF, Oddsson LI, De Luca CJ (2004) The role of plantar cutaneous sensation in 
unperturbed stance. Experimental brain research 156:505-512. 
Murphy PR, Martin HA (1993) Fusimotor discharge patterns during rhythmic movements. 
Trends in neurosciences 16:273-278. 
Murray KC, Stephens MJ, Ballou EW, Heckman CJ, Bennett DJ (2011) Motoneuron 
excitability and muscle spasms are regulated by 5-HT2B and 5-HT2C receptor 
activity. Journal of neurophysiology 105:731-748. 
Murray KC, Nakae A, Stephens MJ, Rank M, D'Amico J, Harvey PJ, Li X, Harris RL, 
Ballou EW, Anelli R, Heckman CJ, Mashimo T, Vavrek R, Sanelli L, Gorassini 
MA, Bennett DJ, Fouad K (2010) Recovery of motoneuron and locomotor 
function after spinal cord injury depends on constitutive activity in 5-HT2C 
receptors. Nature medicine 16:694-700. 
Myslinski NR, Anderson EG (1978) The effect of serotonin precursors on alpha- and 
gamma-motoneuron activity. The Journal of pharmacology and experimental 
therapeutics 204:19-26. 
Nardelli P, Vincent JA, Powers R, Cope TC, Rich MM (2016) Reduced motor neuron 
excitability is an important contributor to weakness in a rat model of sepsis. 
Experimental neurology 282:1-8. 
Nativi C, Gualdani R, Dragoni E, Di Cesare Mannelli L, Sostegni S, Norcini M, Gabrielli 
G, la Marca G, Richichi B, Francesconi O, Moncelli MR, Ghelardini C, Roelens S 
(2013) A TRPA1 antagonist reverts oxaliplatin-induced neuropathic pain. Sci Rep 
3:2005. 
Nichols TR, Cope TC, Abelew TA (1999) Rapid spinal mechanisms of motor 
coordination. Exercise and sport sciences reviews 27:255-284. 
Nitatori T (1988) The fine structure of human Golgi tendon organs as studied by three-
dimensional reconstruction. Journal of neurocytology 17:27-41. 
Novak KR, Norman J, Mitchell JR, Pinter MJ, Rich MM (2015) Sodium channel slow 
inactivation as a therapeutic target for myotonia congenita. Annals of neurology 
77:320-332. 
Novak KR, Nardelli P, Cope TC, Filatov G, Glass JD, Khan J, Rich MM (2009) 
Inactivation of sodium channels underlies reversible neuropathy during critical 
illness in rats. The Journal of clinical investigation 119:1150-1158. 
 
 
143 
Park SB, Lin CS, Kiernan MC (2012a) Nerve excitability assessment in chemotherapy-
induced neurotoxicity. Journal of visualized experiments : JoVE. 
Park SB, Koltzenburg M, Lin CS, Kiernan MC (2012b) Longitudinal assessment of 
oxaliplatin-induced neuropathy. Neurology 78:152. 
Park SB, Lin CS, Krishnan AV, Goldstein D, Friedlander ML, Kiernan MC (2009a) 
Oxaliplatin-induced neurotoxicity: changes in axonal excitability precede 
development of neuropathy. Brain : a journal of neurology 132:2712-2723. 
Park SB, Goldstein D, Lin CS, Krishnan AV, Friedlander ML, Kiernan MC (2009b) Acute 
abnormalities of sensory nerve function associated with oxaliplatin-induced 
neurotoxicity. Journal of clinical oncology : official journal of the American Society 
of Clinical Oncology 27:1243-1249. 
Park SB, Lin CS, Krishnan AV, Goldstein D, Friedlander ML, Kiernan MC (2011a) Long-
term neuropathy after oxaliplatin treatment: challenging the dictum of reversibility. 
The oncologist 16:708-716. 
Park SB, Lin CS, Krishnan AV, Goldstein D, Friedlander ML, Kiernan MC (2011b) Dose 
effects of oxaliplatin on persistent and transient Na+ conductances and the 
development of neurotoxicity. PloS one 6:e18469. 
Park SB, Goldstein D, Krishnan AV, Lin CS, Friedlander ML, Cassidy J, Koltzenburg M, 
Kiernan MC (2013) Chemotherapy-induced peripheral neurotoxicity: a critical 
analysis. CA: a cancer journal for clinicians 63:419-437. 
Perrier JF, Rasmussen HB, Christensen RK, Petersen AV (2013) Modulation of the 
intrinsic properties of motoneurons by serotonin. Curr Pharm Des 19:4371-4384. 
Prather JF, Powers RK, Cope TC (2001) Amplification and linear summation of synaptic 
effects on motoneuron firing rate. Journal of neurophysiology 85:43-53. 
Prochazka A, Ellaway P (2012) Sensory systems in the control of movement. 
Comprehensive Physiology 2:2615-2627. 
Prochazka A, Hulliger M, Zangger P, Appenteng K (1985) 'Fusimotor set': new evidence 
for alpha-independent control of gamma-motoneurones during movement in the 
awake cat. Brain research 339:136-140. 
 
 
144 
Proske U, Gandevia SC (2009) The kinaesthetic senses. The Journal of physiology 
587:4139-4146. 
Proske U, Gandevia SC (2012) The proprioceptive senses: their roles in signaling body 
shape, body position and movement, and muscle force. Physiological reviews 
92:1651-1697. 
Ptak K, Zummo GG, Alheid GF, Tkatch T, Surmeier DJ, McCrimmon DR (2005) Sodium 
currents in medullary neurons isolated from the pre-Botzinger complex region. J 
Neurosci 25:5159-5170. 
Reagan-Shaw S, Nihal M, Ahmad N (2008) Dose translation from animal to human 
studies revisited. FASEB journal : official publication of the Federation of 
American Societies for Experimental Biology 22:659-661. 
Roden-Reynolds DC, Walker MH, Wasserman CR, Dean JC (2015) Hip proprioceptive 
feedback influences the control of mediolateral stability during human walking. 
Journal of neurophysiology 114:2220-2229. 
Rothwell JC, Traub MM, Day BL, Obeso JA, Thomas PK, Marsden CD (1982) Manual 
motor performance in a deafferented man. Brain : a journal of neurology 105 (Pt 
3):515-542. 
Rush AM, Cummins TR, Waxman SG (2007) Multiple sodium channels and their roles in 
electrogenesis within dorsal root ganglion neurons. The Journal of physiology 
579:1-14. 
Sereno M, Gutierrez-Gutierrez G, Gomez-Raposo C, Lopez-Gomez M, Merino-Salvador 
M, Tebar FZ, Rodriguez-Antona C, Casado E (2014) Oxaliplatin induced-
neuropathy in digestive tumors. Critical reviews in oncology/hematology 89:166-
178. 
Sghirlanzoni A, Pareyson D, Lauria G (2005) Sensory neuron diseases. The Lancet 
Neurology 4:349-361. 
Shemmell J, Krutky MA, Perreault EJ (2010) Stretch sensitive reflexes as an adaptive 
mechanism for maintaining limb stability. Clinical neurophysiology : official journal 
of the International Federation of Clinical Neurophysiology 121:1680-1689. 
Sittl R, Lampert A, Huth T, Schuy ET, Link AS, Fleckenstein J, Alzheimer C, Grafe P, 
Carr RW (2012) Anticancer drug oxaliplatin induces acute cooling-aggravated 
neuropathy via sodium channel subtype Na(V)1.6-resurgent and persistent 
 
 
145 
current. Proceedings of the National Academy of Sciences of the United States 
of America 109:6704-6709. 
Stefani A, Spadoni F, Bernardi G (1997) Differential inhibition by riluzole, lamotrigine, 
and phenytoin of sodium and calcium currents in cortical neurons: implications 
for neuroprotective strategies. Experimental neurology 147:115-122. 
Stephens JA, Reinking RM, Stuart DG (1975) Tendon organs of cat medial 
gastrocnemius: responses to active and passive forces as a function of muscle 
length. Journal of neurophysiology 38:1217-1231. 
Swash M, Fox KP (1972) Muscle spindle innervation in man. Journal of anatomy 112:61-
80. 
Taleb O, Bouzobra F, Tekin-Pala H, Meyer L, Mensah-Nyagan AG, Patte-Mensah C 
(2017) Behavioral and electromyographic assessment of oxaliplatin-induced 
motor dysfunctions: Evidence for a therapeutic effect of allopregnanolone. 
Behavioural brain research 320:440-449. 
Taylor A, Ellaway PH, Durbaba R, Rawlinson S (2000a) Distinctive patterns of static and 
dynamic gamma motor activity during locomotion in the decerebrate cat. The 
Journal of physiology 529 Pt 3:825-836. 
Taylor A, Durbaba R, Ellaway PH, Rawlinson S (2000b) Patterns of fusimotor activity 
during locomotion in the decerebrate cat deduced from recordings from hindlimb 
muscle spindles. The Journal of physiology 522 Pt 3:515-532. 
Taylor A, Durbaba R, Ellaway PH, Rawlinson S (2006) Static and dynamic gamma-
motor output to ankle flexor muscles during locomotion in the decerebrate cat. 
The Journal of physiology 571:711-723. 
Theiss RD, Kuo JJ, Heckman CJ (2007) Persistent inward currents in rat ventral horn 
neurones. The Journal of physiology 580:507-522. 
Tofthagen C, Overcash J, Kip K (2012) Falls in persons with chemotherapy-induced 
peripheral neuropathy. Supportive care in cancer : official journal of the 
Multinational Association of Supportive Care in Cancer 20:583-589. 
Urbani A, Belluzzi O (2000) Riluzole inhibits the persistent sodium current in mammalian 
CNS neurons. The European journal of neuroscience 12:3567-3574. 
 
 
146 
Vincent JA, Nardelli P, Gabriel HM, Deardorff AS, Cope TC (2015) Complex impairment 
of IA muscle proprioceptors following traumatic or neurotoxic injury. Journal of 
anatomy 227:221-230. 
Walsh LD, Gandevia SC, Taylor JL (2010) Illusory movements of a phantom hand grade 
with the duration and magnitude of motor commands. The Journal of physiology 
588:1269-1280. 
Wang YJ, Lin MW, Lin AA, Wu SN (2008) Riluzole-induced block of voltage-gated Na+ 
current and activation of BKCa channels in cultured differentiated human skeletal 
muscle cells. Life sciences 82:11-20. 
Wilson RH, Lehky T, Thomas RR, Quinn MG, Floeter MK, Grem JL (2002) Acute 
oxaliplatin-induced peripheral nerve hyperexcitability. Journal of clinical oncology 
: official journal of the American Society of Clinical Oncology 20:1767-1774. 
Witkamp RF (2011) Current and future drug targets in weight management. Pharm Res 
28:1792-1818. 
Witney AG, Wing A, Thonnard JL, Smith AM (2004) The cutaneous contribution to 
adaptive precision grip. Trends in neurosciences 27:637-643. 
Woo SH, Lukacs V, de Nooij JC, Zaytseva D, Criddle CR, Francisco A, Jessell TM, 
Wilkinson KA, Patapoutian A (2015) Piezo2 is the principal mechanotransduction 
channel for proprioception. Nat Neurosci 18:1756-1762. 
Wu SN, Chen BS, Wu YH, Peng H, Chen LT (2009) The mechanism of the actions of 
oxaliplatin on ion currents and action potentials in differentiated NG108-15 
neuronal cells. Neurotoxicology 30:677-685. 
Xie RG, Zheng DW, Xing JL, Zhang XJ, Song Y, Xie YB, Kuang F, Dong H, You SW, Xu 
H, Hu SJ (2011) Blockade of persistent sodium currents contributes to the 
riluzole-induced inhibition of spontaneous activity and oscillations in injured DRG 
neurons. PloS one 6:e18681. 
Zelena J (1994) Nerves and Mechanoreceptors. London: Chapman and Hall. 
Zelena J, Soukup T (1983) The in-series and in-parallel components in rat hindlimb 
tendon organs. Neuroscience 9:899-910. 
 
 
147 
Zeng J, Powers RK, Newkirk G, Yonkers M, Binder MD (2005) Contribution of persistent 
sodium currents to spike-frequency adaptation in rat hypoglossal motoneurons. 
Journal of neurophysiology 93:1035-1041. 
Zhao M, Isami K, Nakamura S, Shirakawa H, Nakagawa T, Kaneko S (2012) Acute cold 
hypersensitivity characteristically induced by oxaliplatin is caused by the 
enhanced responsiveness of TRPA1 in mice. Mol Pain 8:55. 
Zimmerman A, Bai L, Ginty DD (2014) The gentle touch receptors of mammalian skin. 
Science 346:950-954.
 
 
148 
 
 
 Appendix A:  Commonly used Abbreviations 
 
OX  Oxaliplatin 
CIPN  Chemotherapy induced peripheral neuropathy 
PIC  Persistent inward current 
NaPIC  Sodium persistent inward current 
SNAP  Sensory nerve action potential 
STA  Spike triggered averaging 
EMG  Electromyograph  
I.P.  Intraperitoneal 
Mg/LgS Medial gastrocnemius/Lateral gastrocnemius and Soleus muscles 
DV/DT  Rate of rise of action potential 
DEG/ENaC Mechanically gated Na+ channel 
Peizo 2 Mechanically gated ion channel 
CI  Confidence Interval 
nA  Nanoamps 
ms  Millisecond 
mg/kg  Milligrams/kilogram  
NaV  Voltage-gated Na+ channel 
PCO2  Partial pressure expired carbon dioxide 
µm  Micrometers  
Ril  Riluzole
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OX  Oxaliplatin 
Ia  primary muscle spindle afferent 
Group II Secondary muscle spindle afferent 
Ib  Primary golgi tendon organ afferent 
 
 
